syndrome	score	normalized_score
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	2.0	100.0
MYOCLONIC EPILEPSY OF LAFORA	1.5181307999999998	75.90653999999999
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5025641	75.12820500000001
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.492658882	74.6329441
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	1.336812851	66.84064255
D-2-HYDROXYGLUTARIC ACIDURIA 1	1.311283633	65.56418165
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	65.27777999999999
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.1	55.00000000000001
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.09375971	54.6879855
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0858974	54.294869999999996
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0833333	54.166665
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.0598612800000002	52.99306400000001
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.044608482	52.23042409999999
ABLEPHARON-MACROSTOMIA SYNDROME	1.0434783	52.173915
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.034825913	51.74129565
MOWAT-WILSON SYNDROME; MOWS	1.026985331	51.349266549999996
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.0223253829999999	51.116269149999994
TRANSSEXUALITY	1.0188679	50.943395
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	1.016248022	50.8124011
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	1.014687861	50.73439305
MEVALONIC ACIDURIA; MEVA	1.013772082	50.6886041
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	1.0133333	50.666665
FRONTONASAL DYSPLASIA 1; FND1	1.01029958	50.514979000000004
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.00724638	50.362319
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	1.00440529	50.2202645
SPLENOPORTAL VASCULAR ANOMALIES	1.00440529	50.2202645
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	1.004323733	50.216186650000004
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0025641	50.128205
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0025641	50.128205
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.001759633	50.08798165
HYDROXYKYNURENINURIA	1.000843882	50.0421941
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	1.0	50.0
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	50.0
AGENESIS OF CEREBRAL WHITE MATTER	1.0	50.0
WILSON DISEASE	1.0	50.0
PHEOCHROMOCYTOMA	1.0	50.0
HAMAMY SYNDROME; HMMS	1.0	50.0
HEPATOCELLULAR CARCINOMA	1.0	50.0
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	50.0
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	50.0
#615207 IL21R IMMUNODEFICIENCY	1.0	50.0
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	47.42063
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.891762133	44.58810665
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.8600871099999999	43.004355499999996
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.765549782	38.277489100000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	31.94443
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.6388886	31.94443
HALOTHANE HEPATITIS	0.6147059	30.735295
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.6129444230000001	30.647221150000004
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.6091529	30.457645
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.6015406209999999	30.07703105
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.6006777000000001	30.033885000000005
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.6	30.0
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	30.0
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.6	30.0
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.5868128509999999	29.340642549999995
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.583333	29.16665
THROMBOCYTOPENIA 1	0.583333	29.16665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.57455043	28.727521499999998
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.56125229	28.0626145
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.5555556	27.777780000000003
COMBINED SAPOSIN DEFICIENCY	0.55007421	27.5037105
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.545966451	27.298322549999998
AICARDI-GOUTIERES SYNDROME 5	0.538402192	26.920109599999996
Congenital disorder of glycosylation, type IIh	0.5383537119999999	26.917685599999995
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	26.8885991
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	26.785715
TRICHOHEPATOENTERIC SYNDROME 1	0.5333333	26.666665000000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.529522262	26.4761131
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.526205683	26.31028415
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	25.735295
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.510380323	25.519016150000002
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.51008711	25.5043555
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.508117253	25.40586265
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.508090262	25.4045131
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.50680272	25.340136
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.505382823	25.269141150000003
IMMUNODEFICIENCY 36; IMD36	0.50440529	25.2202645
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.5017596329999999	25.087981649999996
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.500915751	25.04578755
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.500915751	25.04578755
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.500915751	25.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.500843882	25.0421941
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	25.0
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	25.0
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	25.0
BRANCHIOOTORENAL SYNDROME 1	0.5	25.0
247150 LIP PRINTS	0.5	25.0
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	25.0
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	25.0
PHLEBECTASIA OF LIPS	0.5	25.0
IMMUNE DEFICIENCY DISEASE	0.5	25.0
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.49956068200000003	24.978034100000002
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	23.318445
CENTRALOPATHIC EPILEPSY	0.4484126	22.42063
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	22.420629999999996
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	22.420629999999996
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.4192311	20.961555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.406349172	20.3174586
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.38995401100000004	19.49770055
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.38940120000000006	19.470060000000004
PSEUDOXANTHOMA ELASTICUM; PXE	0.38361402	19.180701
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	19.123935
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	19.123935
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.379680632	18.9840316
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	18.76369
EPILEPSY, JUVENILE ABSENCE	0.3752738	18.76369
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.373435902	18.6717951
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.37203189999999997	18.601595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.372024453	18.60122265
AICARDI SYNDROME; AIC	0.3704545	18.522725
PROPIONIC ACIDEMIA	0.36483824299999995	18.241912149999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	18.128439099999998
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	18.06758
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	17.98244
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.358422572	17.9211286
ALSTROM SYNDROME; ALMS	0.353437602	17.6718801
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.349691851	17.48459255
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.349691851	17.48459255
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	17.401944999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.341619382	17.0809691
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.33901482	16.950741
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.33659033	16.8295165
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.33509263300000003	16.75463165
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.335092633	16.75463165
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.334248751	16.71243755
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.334248751	16.71243755
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.334248751	16.71243755
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.334248751	16.71243755
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.334176882	16.7088441
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.333333	16.66665
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.333333	16.66665
DANDY-WALKER SYNDROME	0.333333	16.66665
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.333333	16.66665
PARAGANGLIOMAS 3	0.333333	16.66665
PARAGANGLIOMAS 4	0.333333	16.66665
IMMUNODEFICIENCY 46; IMD46	0.333333	16.66665
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.333333	16.66665
PARAGANGLIOMAS 1	0.333333	16.66665
GRANGE SYNDROME; GRNG	0.333333	16.66665
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.333333	16.66665
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.333333	16.66665
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.333333	16.66665
PSEUDO-VON WILLEBRAND DISEASE	0.333333	16.66665
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.330641882	16.5320941
TUBEROUS SCLEROSIS	0.32591575100000003	16.29578755
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.319991041	15.999552049999998
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.304391233	15.21956165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.293584882	14.6792441
#602398 DESMOSTEROLOSIS	0.288567063	14.428353150000001
GLUTAMINE DEFICIENCY, CONGENITAL	0.286551281	14.32756405
MYASTHENIA GRAVIS; MG	0.2833333	14.166665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.280922712	14.046135600000001
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	13.235294999999999
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.262059213	13.10296065
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.26093099200000003	13.046549600000002
LOWE OCULOCEREBRORENAL SYNDROME	0.259112471	12.95562355
Pontine tegmental cap dysplasia	0.258967053	12.94835265
INFANTILE LIVER FAILURE SYNDROME 2	0.258162131	12.908106550000001
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.25568182	12.784091
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.254538941	12.726947050000001
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.254499981	12.72499905
CEPHALIN LIPIDOSIS	0.25408163	12.704081500000001
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.253479851	12.67399255
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.251759633	12.58798165
HYPEREKPLEXIA 1; HKPX1	0.25	12.5
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	12.5
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	12.5
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.25	12.5
HYPERPARATHYROIDISM 2	0.25	12.5
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	12.5
DYSTONIA 6, TORSION	0.25	12.5
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	12.5
118900 CIRRHOSIS, FAMILIAL	0.25	12.5
TUFTSIN DEFICIENCY	0.25	12.5
CEROID STORAGE DISEASE	0.25	12.5
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.25	12.5
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	12.5
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.5
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.25	12.5
PATENT DUCTUS VENOSUS	0.25	12.5
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.25	12.5
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	12.5
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	11.221404999999999
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	11.221404999999999
LATHOSTEROLOSIS	0.22084008100000002	11.042004050000001
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.213964553	10.69822765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.211713482	10.5856741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.211713482	10.5856741
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.21020184300000005	10.510092150000002
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.208608351	10.43041755
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.20440529000000002	10.2202645
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.20256410000000002	10.128205000000001
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.20175963300000002	10.087981650000001
COHEN SYNDROME	0.200915751	10.04578755
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.200915751	10.04578755
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.200843882	10.0421941
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.200843882	10.0421941
PHELAN-MCDERMID SYNDROME; PHMDS	0.20005965299999998	10.002982649999998
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.2	10.0
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.199328351	9.96641755
PEHO-LIKE SYNDROME; PEHOL	0.19684353200000002	9.8421766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	9.720704099999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.19089518100000002	9.544759050000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.18949305300000002	9.474652650000001
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.18592319000000002	9.296159500000002
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	9.1071691
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	9.064975
COFFIN-SIRIS SYNDROME 6; CSS6	0.17896493200000002	8.948246600000001
ADAMS-OLIVER SYNDROME 1; AOS1	0.178813583	8.94067915
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17718612	8.859306
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.175396023	8.769801150000001
NIEMANN-PICK DISEASE, TYPE C2	0.175396023	8.769801150000001
PEHO SYNDROME; PEHO	0.17526819300000002	8.763409650000002
CHROMOSOME 1P36 DELETION SYNDROME	0.17209596299999996	8.604798149999999
PYRUVATE CARBOXYLASE DEFICIENCY	0.168426633	8.421331649999999
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.168426633	8.421331649999999
GLUTARIC ACIDEMIA I; GA1	0.167582751	8.37913755
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.16739089	8.3695445
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.166667	8.333350000000001
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.166667	8.333350000000001
#613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.166667	8.333350000000001
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.166667	8.333350000000001
GLYCEROL KINASE DEFICIENCY; GKD	0.163484533	8.17422665
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.157244382	7.862219099999999
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.15612550200000003	7.8062751000000015
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.15196899000000003	7.598449500000001
DUBOWITZ SYNDROME	0.14611433	7.305716499999999
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	7.185044099999999
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.141755841	7.08779205
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.1405258	7.02629
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.140297712	7.0148855999999995
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.14006922	7.003461
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.13952911199999998	6.9764555999999995
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.139377251	6.968862550000001
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.13736028	6.8680140000000005
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.136802433	6.84012165
219400 CYANOSIS AND HEPATIC DISEASE	0.1357143	6.785715000000001
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	6.7212250000000004
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.13328778100000002	6.664389050000001
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.13327874300000003	6.6639371500000015
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.13289672000000002	6.6448360000000015
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	6.49986905
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	6.29578755
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.12581710000000002	6.2908550000000005
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	6.287195
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.123498803	6.17494015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.123037641	6.15188205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.12169149000000001	6.0845745
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.12029108200000001	6.014554100000001
MUCOLIPIDOSIS IV; ML4	0.11989148200000002	5.994574100000001
COFFIN-SIRIS SYNDROME 2; CSS2	0.118716123	5.93580615
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.11864273300000001	5.93213665
WHITE-SUTTON SYNDROME; WHSUS	0.116248022	5.812401100000001
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.115525172	5.776258599999999
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.11224388	5.612194000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.11193296300000001	5.596648150000001
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.10818720000000001	5.40936
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	5.405435
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.10750485100000001	5.37524255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.10652570200000001	5.326285100000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10568182000000001	5.284091
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.10555107100000001	5.27755355
COFFIN-SIRIS SYNDROME 3; CSS3	0.105382823	5.26914115
COFFIN-SIRIS SYNDROME 4; CSS4	0.105382823	5.26914115
WITTEVEEN-KOLK SYNDROME	0.105267793	5.26338965
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.10440529000000001	5.220264500000001
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.10440529000000001	5.220264500000001
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.10396083300000002	5.19804165
MEIER-GORLIN SYNDROME 5; MGORS5	0.10362319	5.181159500000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.10347985100000001	5.17399255
JOUBERT SYNDROME 7	0.10340798200000001	5.170399100000001
JOUBERT SYNDROME 2	0.10340798200000001	5.170399100000001
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.10325733000000001	5.162866500000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.102867372	5.1433686
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.10259372000000001	5.129686
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.10259372000000001	5.129686
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.1025641	5.128205
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.10091575100000001	5.045787550000001
IMMUNODEFICIENCY 37; IMD37	0.10091575100000001	5.045787550000001
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	5.045787550000001
TARP SYNDROME; TARPS	0.10084388200000001	5.042194100000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.10084388200000001	5.042194100000001
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.10084388200000001	5.042194100000001
NIEMANN-PICK DISEASE, TYPE B	0.10019629000000002	5.009814500000001
KRABBE DISEASE	0.100073931	5.00369655
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1	5.0
HEPATITIS B VACCINE, RESPONSE TO	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	5.0
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	5.0
DYSTONIA, JUVENILE-ONSET	0.1	5.0
PANENCEPHALITIS, SUBACUTE SCLEROSING	0.1	5.0
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	5.0
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.1	5.0
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	5.0
TRICHOHEPATOENTERIC SYNDROME 2	0.1	5.0
SECKEL SYNDROME 2; SCKL2	0.1	5.0
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.099001851	4.95009255
COACH SYNDROME	0.098865043	4.94325215
HEART AND BRAIN MALFORMATION SYNDROME	0.09872645300000002	4.936322650000001
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.09771182	4.885591
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.09729785300000002	4.864892650000001
CHROMOSOME 17q12 DELETION SYNDROME	0.09727443000000001	4.8637215000000005
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	4.8317441
FISH-EYE DISEASE	0.09579100000000002	4.789550000000001
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.09579100000000002	4.789550000000001
ATHEROSCLEROSIS SUSCEPTIBILITY	0.09579100000000002	4.789550000000001
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.09579100000000002	4.789550000000001
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.09563090000000002	4.781545000000001
SITOSTEROLEMIA	0.09531439000000001	4.7657195
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.09518804	4.759402
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.7495365000000005
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.09237390200000001	4.6186951
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.091934493	4.5967246500000005
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	4.5912425500000005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.09157515100000002	4.578757550000001
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0913799	4.568995
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.09129130100000002	4.564565050000001
EVEN-PLUS SYNDROME	0.09121943200000002	4.560971600000001
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	4.5454550000000005
RCAD (renal cysts and diabetes)	0.0909091	4.5454550000000005
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	4.5454550000000005
ATRANSFERRINEMIA	0.0909091	4.5454550000000005
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.5454550000000005
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.09036447200000002	4.518223600000001
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.089221841	4.4610920499999995
RHEUMATOID ARTHRITIS	0.08791550000000001	4.395775
GABRIELE-DE VRIES SYNDROME; GADEVS	0.087511872	4.3755936
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.08691753	4.3458765
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.08509293300000001	4.254646650000001
CAROLI DISEASE, ISOLATED	0.08427718	4.213858999999999
JOUBERT SYNDROME 23; JBTS23	0.08417718200000002	4.208859100000001
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.08417718200000002	4.208859100000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.083341861	4.16709305
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.08333330000000001	4.166665000000001
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.08333330000000001	4.166665000000001
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.083004212	4.150210599999999
ACROCALLOSAL SYNDROME; ACLS	0.08264393100000002	4.132196550000001
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.08260492000000001	4.1302460000000005
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.082195961	4.10979805
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.081665561	4.08327805
TANGIER DISEASE; TGD	0.08132839000000001	4.0664195
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.079832	3.9916
LISSENCEPHALY, X-LINKED, 2	0.079820401	3.99102005
MYOCLONUS AND ATAXIA	0.07948720000000001	3.9743600000000003
WILLIAMS-BEUREN SYNDROME; WBS	0.07920907	3.9604535000000003
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	3.943445
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.078688741	3.9344370500000005
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.078421122	3.9210561
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	3.90625
LISSENCEPHALY 2; LIS2	0.07776698200000001	3.8883491000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.077465753	3.87328765
MENTAL RETARDATION, X-LINKED 98; MRX98	0.077376313	3.86881565
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.07692310000000001	3.8461550000000004
CANAVAN DISEASE	0.07692310000000001	3.8461550000000004
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	3.8461550000000004
HYPERLIPOPROTEINEMIA, TYPE V	0.07692310000000001	3.8461550000000004
MCLEOD SYNDROME; MCLDS	0.07692310000000001	3.8461550000000004
Polyarteritis nodosa, childhood-onset	0.07609701	3.8048505
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.07560168100000002	3.780084050000001
MICROHYDRANENCEPHALY; MHAC	0.07529885	3.7649425
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.07468593000000001	3.7342965000000006
LISSENCEPHALY 5; LIS5	0.074652351	3.7326175500000005
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	3.721175
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	3.721175
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.07318823300000002	3.659411650000001
MYELOPEROXIDASE DEFICIENCY	0.07312923000000002	3.6564615000000007
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0728901	3.644505
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.07234435100000002	3.617217550000001
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.07227248200000001	3.6136241000000004
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.072001483	3.60007415
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07186239999999999	3.59312
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.07142860000000001	3.5714300000000003
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.07142860000000001	3.5714300000000003
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.513075
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.06946939	3.4734695
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.069446533	3.4723266500000003
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.069384212	3.4692106000000003
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.068838722	3.4419361000000004
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.068775243	3.43876215
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.068716123	3.4358061500000003
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.06866378100000001	3.43318905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.06836715099999999	3.418357549999999
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.06716377300000001	3.3581886500000007
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.06690529	3.3452645000000003
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.06690529	3.3452645000000003
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.06690529	3.3452645000000003
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.06659063000000001	3.3295315000000008
#154780 MARSHALL SYNDROME; MRSHS	0.06659063000000001	3.3295315000000008
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.0660173	3.300865
ANGELMAN SYNDROME	0.065511953	3.27559765
KABUKI SYNDROME 1	0.064259633	3.2129816499999997
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.06424905100000002	3.212452550000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.064177182	3.2088590999999997
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	3.20815
COFFIN-SIRIS SYNDROME 1; CSS1	0.064131663	3.20658315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.063696243	3.18481215
Growth hormone deficiency, isolated, type IA	0.0636363	3.1818150000000003
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.063502523	3.17512615
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.06333330000000001	3.1666650000000005
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	3.162195
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	3.162195
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.062960881	3.1480440499999998
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0625	3.125
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0625	3.125
IMMUNODEFICIENCY 62; IMD62	0.0625	3.125
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.0625	3.125
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0625	3.125
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0625	3.125
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0625	3.125
SMITH-MAGENIS SYNDROME; SMS	0.062157553000000004	3.1078776500000003
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.062152283	3.1076141500000003
YUNIS-VARON SYNDROME	0.061987350000000004	3.0993675
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.060621713	3.03108565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.060380323	3.01901615
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	2.9944800000000003
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.059451933000000005	2.9725966500000003
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.059404321	2.9702160500000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.059139830000000004	2.9569915
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.059035451	2.9517725500000003
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.05882701	2.9413505
MOEBIUS SYNDROME; MBS	0.058812930000000006	2.9406465
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.058608051	2.93040255
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.058601193	2.93005965
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.058488072	2.9244036
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.05836681	2.9183405
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.058274212000000006	2.9137106000000004
CYCLIC NEUTROPENIA	0.058184200000000005	2.9092100000000003
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0581197	2.9059850000000003
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.0581197	2.9059850000000003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0581197	2.9059850000000003
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0581197	2.9059850000000003
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.86647
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.057131581	2.85657905
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	2.832335
TENORIO SYNDROME; TNORS	0.056471351	2.82356755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	2.8199741
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.056399482	2.8199741
YOU-HOOVER-FONG SYNDROME; YHFS	0.056039582	2.8019791
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.7777800000000004
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.055555600000000004	2.7777800000000004
MYOPATHY, DISTAL 3	0.055555600000000004	2.7777800000000004
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.7777800000000004
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.7777800000000004
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.7777800000000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.7777800000000004
DYSTONIA 7, TORSION	0.055555600000000004	2.7777800000000004
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.055555600000000004	2.7777800000000004
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.055555600000000004	2.7777800000000004
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.054961913	2.7480956500000002
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.054919072	2.7459536
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.054825490000000004	2.7412745000000003
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.054796731	2.73983655
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.7291100000000004
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	2.72529
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0545058	2.72529
EPILEPSY, PYRIDOXINE-DEPENDENT	0.054124312	2.7062156
OGDEN SYNDROME; OGDNS	0.054101212	2.7050606
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.054101212	2.7050606
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.05407519	2.7037595000000003
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.053906363	2.69531815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.053654282	2.6827141
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0535793	2.6789650000000003
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.05328878000000001	2.6644390000000002
NASODIGITOACOUSTIC SYNDROME	0.053257330000000005	2.6628665000000002
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.053035563	2.65177815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.052979582	2.6489791
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.052710551	2.63552755
LAMB-SHAFFER SYNDROME	0.052663712	2.6331856
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.052606350999999996	2.63031755
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.052518902000000006	2.6259451000000005
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.052253181	2.61265905
SCLEROSING CHOLANGITIS, NEONATAL	0.05202429	2.6012145
HARDIKAR SYNDROME	0.05202429	2.6012145
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05202429	2.6012145
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.051657619999999994	2.5828809999999995
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.05165208	2.5826040000000003
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.051086332000000005	2.5543166000000004
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.050798363	2.53991815
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.050355471	2.51777355
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	2.51488165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.050246851	2.51234255
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0501831	2.5091550000000002
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.05	2.5
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.05	2.5
KEIPERT SYNDROME; KPTS	0.05	2.5
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.05	2.5
DIAMOND-BLACKFAN ANEMIA 8	0.05	2.5
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.049827483000000006	2.4913741500000004
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.049555712	2.4777856000000003
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.049378633	2.46893165
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0491709	2.458545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.04903873	2.4519365
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.048885982	2.4442991000000003
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.4269
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.4269
GITELMAN SYNDROME	0.048334750999999995	2.4167375499999997
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.048279699999999995	2.413985
RAGWEED SENSITIVITY	0.048039200000000004	2.4019600000000003
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.048039200000000004	2.4019600000000003
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.047964292	2.3982145999999998
ADAMS-OLIVER SYNDROME 6; AOS6	0.047619	2.38095
GLYCOGEN STORAGE DISEASE IV	0.047619	2.38095
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.047619	2.38095
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.047619	2.38095
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.047619	2.38095
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.047619	2.38095
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.047214133	2.36070665
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.047214133	2.36070665
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.047202753	2.36013765
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.047025072	2.3512536
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.04698007	2.3490035
SHPRINTZEN OMPHALOCELE SYNDROME	0.04673563000000001	2.3367815000000003
HYPOADRENOCORTICISM, FAMILIAL	0.046623631	2.33118155
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.046370251	2.31851255
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.046370251	2.31851255
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.046298382	2.3149191
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.046274772000000006	2.3137386
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.046108102	2.3054050999999998
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.045492672000000005	2.2746336
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0454545	2.272725
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0454545	2.272725
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.045452212	2.2726106
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.045420543	2.27102715
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.045303060000000006	2.265153
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.045287282	2.2643641
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.044914382	2.2457191
KAGAMI-OGATA SYNDROME	0.044626423000000005	2.2313211500000003
NAVAJO NEUROHEPATOPATHY	0.043987662000000004	2.1993831000000004
POTOCKI-LUPSKI SYNDROME	0.043805363	2.19026815
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.043805363	2.19026815
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.043770453	2.18852265
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.04371362300000001	2.18568115
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0435858	2.17929
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.173915
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.173915
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	2.173915
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.173915
LIP, HAMARTOMATOUS	0.043478300000000004	2.173915
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.173915
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.173915
BAZEX SYNDROME; BZX	0.043478300000000004	2.173915
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.173915
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.173915
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.173915
MAL DE MELEDA	0.043478300000000004	2.173915
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	2.173915
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.043216593	2.1608296499999997
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.042961481	2.14807405
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.042889612	2.1444806
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.04284405299999999	2.1422026499999998
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.042756550000000004	2.1378275
COHEN-GIBSON SYNDROME; COGIS	0.042562712	2.1281356000000002
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.04251702	2.125851
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.04243479	2.1217395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.042356223	2.11781115
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.042247353	2.11236765
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.04204573	2.1022865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.04198138	2.099069
HAREL-YOON SYNDROME; HAYOS	0.041967662	2.0983831
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.0932790999999997
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.0932790999999997
ACRORENAL-MANDIBULAR SYNDROME	0.041718830000000005	2.0859415
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.041717912999999995	2.08589565
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.041664062	2.0832031
LISSENCEPHALY 1; LIS1	0.041630323	2.0815161499999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.041459123	2.07295615
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.04131735	2.0658675
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.040714572000000004	2.0357286
INFANTILE LIVER FAILURE SYNDROME 1	0.040221133000000006	2.0110566500000004
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.040221133000000006	2.0110566500000004
MEND SYNDROME; MEND	0.040221133000000006	2.0110566500000004
CHROMOSOME 5Q12 DELETION SYNDROME	0.040221133000000006	2.0110566500000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.040221133000000006	2.0110566500000004
COUMARIN RESISTANCE	0.03979593000000001	1.9897965000000004
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.9897965000000004
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.9897965000000004
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03979593000000001	1.9897965000000004
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.9897965000000004
FLOOD FACTOR DEFICIENCY	0.03979593000000001	1.9897965000000004
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.03979593000000001	1.9897965000000004
MACROCYTOSIS, FAMILIAL	0.03979593000000001	1.9897965000000004
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03979593000000001	1.9897965000000004
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.039556151	1.9778075499999999
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.039543402000000005	1.9771701000000004
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.039508222999999995	1.9754111499999998
MYELOCEREBELLAR DISORDER	0.039495920000000004	1.9747960000000002
COWDEN SYNDROME 5; CWS5	0.039377251	1.96886255
COWDEN SYNDROME 6; CWS6	0.039377251	1.96886255
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.039377251	1.96886255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.039305382	1.9652691
SILVER-RUSSELL SYNDROME; SRS	0.039305382	1.9652691
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.039305382	1.9652691
SWEENEY-COX SYNDROME; SWCOS	0.039305382	1.9652691
CHROMOSOME 15q25 DELETION SYNDROME	0.039305382	1.9652691
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.039028792	1.9514396
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.03897163000000001	1.9485815000000004
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.038877451	1.94387255
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.923075
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	1.923075
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0384615	1.923075
SOTOS SYNDROME 2	0.0384615	1.923075
SPONDYLOOCULAR SYNDROME; SOS	0.0384615	1.923075
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.923075
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.923075
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.923075
BETHLEM MYOPATHY 1	0.0384615	1.923075
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.923075
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.923075
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0384615	1.923075
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.923075
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.923075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0384615	1.923075
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.923075
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.923075
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.923075
STICKLER SYNDROME, TYPE II	0.0384615	1.923075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.923075
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0384615	1.923075
ARTERIES, ANOMALIES OF	0.0384615	1.923075
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0384615	1.923075
THUMB DEFORMITY	0.0384615	1.923075
WATSON SYNDROME	0.0384615	1.923075
CHANARIN-DORFMAN SYNDROME	0.038278400000000004	1.9139200000000003
OCULODENTODIGITAL DYSPLASIA; ODDD	0.037987181	1.8993590500000002
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.03797909	1.8989545
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.037906723	1.89533615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.037788802	1.8894401
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.037582773	1.87913865
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.8707465000000003
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.8707465000000003
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.8707465000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.037248712	1.8624356000000002
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.037084683	1.85423415
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.03695649	1.8478245
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03694492	1.847246
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.8464049999999999
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.8464049999999999
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.03665818	1.832909
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.036630051000000004	1.8315025500000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.036376471	1.81882355
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03621452	1.810726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.03615547200000001	1.8077736000000004
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.035952501	1.79762505
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03577162	1.7885809999999998
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.035714300000000004	1.7857150000000002
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7857150000000002
EOSINOPHILOPENIA	0.035714300000000004	1.7857150000000002
HEMOPOIETIC PROLIFERATION	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.035714300000000004	1.7857150000000002
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7857150000000002
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7857150000000002
METHANE PRODUCTION	0.035714300000000004	1.7857150000000002
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.035714300000000004	1.7857150000000002
BLUE DIAPER SYNDROME	0.035714300000000004	1.7857150000000002
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7857150000000002
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7857150000000002
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.7857150000000002
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.035714300000000004	1.7857150000000002
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.035714300000000004	1.7857150000000002
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.7857150000000002
GASTRIC SNEEZING	0.035714300000000004	1.7857150000000002
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.035714300000000004	1.7857150000000002
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.7857150000000002
TERATOMA, PINEAL	0.035714300000000004	1.7857150000000002
ACETOPHENETIDIN SENSITIVITY	0.035714300000000004	1.7857150000000002
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7857150000000002
MYELOMA, MULTIPLE	0.035714300000000004	1.7857150000000002
GIANT NEUTROPHIL LEUKOCYTES	0.035714300000000004	1.7857150000000002
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.7857150000000002
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.035714300000000004	1.7857150000000002
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7857150000000002
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.035714300000000004	1.7857150000000002
SULFHEMOGLOBINEMIA, CONGENITAL	0.035714300000000004	1.7857150000000002
ZUNICH NEUROECTODERMAL SYNDROME	0.035688181	1.78440905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.035655900000000004	1.7827950000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.035573732999999996	1.7786866499999998
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.03546072	1.773036
CHROMOSOME 18Q DELETION SYNDROME	0.035423081	1.77115405
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.035351212	1.7675606
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03533163	1.7665815
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.035168251	1.7584125499999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.03511529	1.7557645
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.03509362	1.754681
IMMUNODEFICIENCY 10; IMD10	0.03509362	1.754681
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0350931	1.754655
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.034989001	1.7494500499999999
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0348873	1.7443650000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.034877202999999996	1.7438601499999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.034825913	1.74129565
MEGALENCEPHALY WITH DYSMYELINATION	0.034729851	1.73649255
METACHROMATIC LEUKODYSTROPHY	0.034729851	1.73649255
PEROXISOME BIOGENESIS DISORDER 6B	0.034657982	1.7328990999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.034395262999999995	1.7197631499999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.034395262999999995	1.7197631499999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.034204572	1.7102286000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.034165612	1.7082806
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.033856851	1.69284255
FAMILIAL MEDITERRANEAN FEVER; FMF	0.03381709	1.6908545000000001
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.03381709	1.6908545000000001
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.033735533	1.6867766499999999
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.67869
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0335738	1.67869
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.033390653	1.66953265
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.666665
IMMUNE SUPPRESSION	0.0333333	1.666665
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.666665
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.666665
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	1.666665
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.666665
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	1.666665
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.666665
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.666665
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.666665
SHORT SYNDROME	0.0333333	1.666665
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.666665
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.666665
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	1.666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.03332173	1.6660865
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.033268783	1.66343915
LETTERER-SIWE DISEASE	0.03320822	1.6604109999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.033145482000000004	1.6572741000000002
STUVE-WIEDEMANN SYNDROME	0.03303499	1.6517495
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.033009633	1.65048165
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0328877	1.644385
GOLDBERG-SHPRINTZEN SYNDROME	0.032710911999999995	1.6355455999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.032532282	1.6266141
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.032417471	1.6208735500000002
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.032370122	1.6185061
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.032296992	1.6148495999999999
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.032165751	1.60828755
Adrenoleukodystrophy	0.032165751	1.60828755
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.032093882	1.6046941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.031954512000000004	1.5977256000000002
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.031908633	1.5954316499999999
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.031908633	1.5954316499999999
WARBURG MICRO SYNDROME 2; WARBM2	0.03143572	1.571786
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.031350893	1.5675446499999999
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03125	1.5625
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03125	1.5625
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	1.5625
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03125	1.5625
15q13.3 microdeletion syndrome	0.031218750999999996	1.5609375499999998
MENKES DISEASE	0.031218750999999996	1.5609375499999998
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	1.5609375499999998
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.031171433	1.55857165
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	1.5573441
HYPOPHOSPHATASIA, INFANTILE	0.031064750999999998	1.55323755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.030961672000000003	1.5480836000000002
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.03073274	1.536637
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.030628613	1.53143065
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.030581382	1.5290691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.030581382	1.5290691
LYSOSOMAL ACID LIPASE DEFICIENCY	0.03051957	1.5259785
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.516545
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.516545
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.516545
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.030327550999999998	1.5163775499999999
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.5151499999999998
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.5151499999999998
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.5151499999999998
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.5151499999999998
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.5151499999999998
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	1.5151499999999998
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.5151499999999998
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.5151499999999998
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.5151499999999998
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.5151499999999998
DIMPLES, FACIAL	0.030302999999999997	1.5151499999999998
CLEFT CHIN	0.030302999999999997	1.5151499999999998
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.5151499999999998
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.5151499999999998
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.5151499999999998
DWARFISM, LEVI TYPE	0.030302999999999997	1.5151499999999998
22q11.2 distal deletion syndrome	0.030302999999999997	1.5151499999999998
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.5151499999999998
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.5151499999999998
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.5151499999999998
OROFACIAL CLEFT 3	0.030302999999999997	1.5151499999999998
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.5151499999999998
NASAL BONES, ABSENCE OF	0.030302999999999997	1.5151499999999998
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.030255682	1.5127841
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.030175682000000002	1.5087841000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0301004	1.50502
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.029984273000000002	1.4992136500000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.029967150999999997	1.49835755
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.029501973	1.47509865
POPOV-CHANG SYNDROME; POPCHAS	0.029451592	1.4725796
DOHLE BODIES AND LEUKEMIA	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 9; IMD9	0.0294118	1.4705899999999998
Yao syndrome	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 61; IMD61	0.0294118	1.4705899999999998
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	1.4705899999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0294118	1.4705899999999998
MAJEED SYNDROME	0.0294118	1.4705899999999998
MARSILI SYNDROME; MARSIS	0.0294118	1.4705899999999998
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.029289382000000003	1.4644691
MYOCLONIC-ATONIC EPILEPSY	0.0288799	1.443995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.028457343000000003	1.42286715
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.028451263	1.42256315
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.028442151	1.42210755
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.028282799999999997	1.4141399999999997
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.02827621	1.4138105
300270 ADRENOMYODYSTROPHY	0.028271402	1.4135701
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.028106190999999996	1.4053095499999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.028033373	1.40166865
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.027934281	1.39671405
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.027793661999999997	1.3896830999999998
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.027755781	1.38778905
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.027737302	1.3868650999999999
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.027579533	1.37897665
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.027579533	1.37897665
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.027579533	1.37897665
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.027427802	1.3713901000000002
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.027353970999999998	1.3676985499999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.027338482	1.3669241
DESANTO-SHINAWI SYNDROME	0.027264773	1.36323865
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.3579841000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.027115940999999998	1.3557970499999998
ERYTHERMALGIA, PRIMARY	0.027064619999999998	1.3532309999999999
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.027027070999999996	1.3513535499999998
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.026919202	1.3459600999999999
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.026898913000000003	1.34494565
XQ25 DUPLICATION SYNDROME	0.026782992999999998	1.33914965
FUMARASE DEFICIENCY; FMRD	0.026754032	1.3377016
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.026735651	1.33678255
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.026689272	1.3344636
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026553342	1.3276671
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.026553342	1.3276671
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0264946	1.32473
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.31579
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.31579
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.026304970999999996	1.3152485499999997
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.026294881	1.31474405
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.026294881	1.31474405
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.025939110999999997	1.2969555499999998
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.025869302000000004	1.2934651000000001
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0258199	1.290995
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.025762862999999997	1.2881431499999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.025670619999999998	1.283531
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.025670619999999998	1.283531
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.025670619999999998	1.283531
CHROMOSOME 13q14 DELETION SYNDROME	0.02556325	1.2781624999999999
PITT-HOPKINS SYNDROME	0.025517201	1.27586005
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02551363	1.2756815
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.025466719999999998	1.273336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.025449733000000002	1.27248665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.025089572	1.2544786
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.025089572	1.2544786
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.025015433	1.25077165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.024873113000000002	1.24365565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.024873113	1.24365565
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.024868592999999998	1.24342965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.024834153	1.2417076500000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.024834153	1.2417076500000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.024613623	1.2306811500000001
WEBB-DATTANI SYNDROME; WEDAS	0.024574663	1.22873315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.024574663	1.22873315
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.024171551	1.20857755
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024171551	1.20857755
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.024171551	1.20857755
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.024099682	1.2049841000000001
OPTIC ATROPHY 11; OPA11	0.024099682	1.2049841000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.024099682	1.2049841000000001
AICARDI-GOUTIERES SYNDROME 7	0.024090623	1.20453115
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.02407272	1.203636
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	1.19909165
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.023730781	1.18653905
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.023724763	1.1862381499999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.023713251	1.18566255
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.023680543	1.18402715
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.023680543	1.18402715
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02365897	1.1829485000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.023654711	1.1827355499999999
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.023532963	1.1766481500000001
ACROMICRIC DYSPLASIA	0.023434299999999998	1.1717149999999998
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.023434299999999998	1.1717149999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.023434299999999998	1.1717149999999998
HURLER SYNDROME	0.023430971999999998	1.1715486
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.023409173	1.1704586499999998
GLYCOGEN STORAGE DISEASE IXC	0.02327319	1.1636595
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02327319	1.1636595
Lipodystrophy, congenital generalized, type 2	0.02327319	1.1636595
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.02327319	1.1636595
APOLIPOPROTEIN C-II DEFICIENCY	0.02327319	1.1636595
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.02327319	1.1636595
Lipodystrophy, congenital generalized, type 1	0.02327319	1.1636595
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.023269563	1.16347815
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	1.16279
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.0232558	1.16279
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0232558	1.16279
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0232558	1.16279
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.023200823000000002	1.16004115
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.023200823000000002	1.16004115
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.023200823000000002	1.16004115
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.023200411	1.16002055
TEMPLE-BARAITSER SYNDROME; TMBTS	0.023198762999999997	1.15993815
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.023198762999999997	1.15993815
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.023191633	1.15958165
HYPERPROLINEMIA, TYPE I	0.023191633	1.15958165
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.023161571	1.15807855
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.023149802	1.1574901
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.023066082	1.1533041000000002
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.1533041000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.1533041000000002
RING CHROMOSOME 14 SYNDROME	0.022969112	1.1484556
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.1474765
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1474765
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1474765
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1474765
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1474765
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.022868030999999997	1.1434015499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.022720741	1.1360370499999999
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.02268951	1.1344755
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.022681780999999998	1.1340890499999998
Retinitis pigmentosa with or without skeletal anomalies	0.022648871999999997	1.1324435999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.022648871999999997	1.1324435999999998
HURLER-SCHEIE SYNDROME	0.022587089999999997	1.1293544999999998
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.02258554	1.129277
TEMPLE SYNDROME	0.02249109	1.1245545
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.02249109	1.1245545
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.022439713	1.12198565
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.022424371	1.12121855
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.02237935	1.1189675
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.022373902	1.1186951
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.022352502	1.1176251
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.022325382999999997	1.11626915
COFFIN-SIRIS SYNDROME 5	0.022300353	1.11501765
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.022283011999999998	1.1141505999999999
THAUVIN-ROBINET-FAIVRE SYNDROME	0.022283011999999998	1.1141505999999999
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.022283011999999998	1.1141505999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.022283011999999998	1.1141505999999999
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.022283011999999998	1.1141505999999999
JOUBERT SYNDROME 10	0.022283011999999998	1.1141505999999999
NOONAN SYNDROME 5; NS5	0.022283011999999998	1.1141505999999999
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.022275882	1.1137941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.022275882	1.1137941
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.022263429999999997	1.1131714999999998
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.11111
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.11111
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.11111
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.11111
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.11111
EPILEPSY, HOT WATER, 1	0.0222222	1.11111
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.022200233	1.11001165
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	1.0976139999999999
MEIER-GORLIN SYNDROME 6; MGORS6	0.021804989999999996	1.0902494999999999
ALLAN-HERNDON-DUDLEY SYNDROME	0.0217949	1.089745
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.021588011	1.0794005500000001
CIRRHOSIS, FAMILIAL	0.02150862	1.075431
HALLERMANN-STREIFF SYNDROME; HSS	0.02150862	1.075431
STIFF-PERSON SYNDROME; SPS	0.02150862	1.075431
FEINGOLD SYNDROME 1; FGLDS1	0.021439129999999997	1.0719564999999998
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.021439129999999997	1.0719564999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.021439129999999997	1.0719564999999998
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.021432	1.0715999999999999
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.021432	1.0715999999999999
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.021409631999999998	1.0704816
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.021284482	1.0642241000000001
EMANUEL SYNDROME	0.021245403	1.06227015
PELGER-HUET ANOMALY; PHA	0.021231602	1.0615801
HADZISELIMOVIC SYNDROME	0.021018742	1.0509371
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.021006803	1.05034015
ADENYLOSUCCINASE DEFICIENCY	0.020990433	1.04952165
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.020990433	1.04952165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.020943671000000004	1.0471835500000002
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.020845073	1.04225365
CHROMOSOME 19p13.13 DELETION SYNDROME	0.020825923	1.04129615
GLYCINE ENCEPHALOPATHY; GCE	0.020778501	1.03892505
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.020767423	1.03837115
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.020767423	1.03837115
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.020728463000000003	1.03642315
NIEMANN-PICK DISEASE, TYPE A	0.020692271999999998	1.0346136
HYPERCALCEMIA, INFANTILE, 1	0.02057968	1.028984
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.020467433	1.02337165
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.020387719999999998	1.019386
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.020387719999999998	1.019386
#256520 NEU-LAXOVA SYNDROME; NLS	0.02037555	1.0187775
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.020334172	1.0167086
SECKEL SYNDROME 7; SCKL7	0.020146551	1.0073275499999998
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.020146551	1.0073275499999998
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.020146551	1.0073275499999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.020146551	1.0073275499999998
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.020074682	1.0037341
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.020066880000000002	1.003344
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.020053111999999998	1.0026556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.019941432999999998	0.9970716499999999
PETTIGREW SYNDROME	0.019941432999999998	0.9970716499999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.019910172	0.9955086
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.019836653000000003	0.9918326500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.019836653000000003	0.9918326500000001
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	0.9855891
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.9855891
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	0.9855891
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.9855891
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.019526790000000002	0.9763395000000001
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.019412051	0.97060255
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.019266633	0.9633316499999999
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0192308	0.96154
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0192308	0.96154
KAPUR-TORIELLO SYNDROME	0.019213471	0.96067355
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01920923	0.9604615000000001
LISSENCEPHALY, X-LINKED, 1; LISX1	0.019142791	0.95713955
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.01911119	0.9555595
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.01911119	0.9555595
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.01911119	0.9555595
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01911119	0.9555595
GLYCOGEN STORAGE DISEASE II	0.01911119	0.9555595
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01911119	0.9555595
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.01911119	0.9555595
IMMUNODEFICIENCY 32B; IMD32B	0.01911119	0.9555595
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.01911119	0.9555595
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.019104851	0.9552425499999999
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.019104851	0.9552425499999999
NOONAN SYNDROME 7; NS7	0.019097550999999997	0.9548775499999999
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.019068053	0.9534026500000001
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.019068053	0.9534026500000001
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.019032982	0.9516491
ALAZAMI SYNDROME; ALAZS	0.019025682	0.9512841
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.943395
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.943395
MYOPATHY, CONGENITAL	0.0188679	0.943395
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.943395
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.943395
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.943395
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.0188679	0.943395
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.943395
#615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	0.0188679	0.943395
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.943395
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.943395
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0188679	0.943395
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.943395
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.943395
JUMPING FRENCHMAN OF MAINE	0.0188679	0.943395
THUMBS, CONGENITAL CLASPED	0.0188679	0.943395
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0188679	0.943395
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.943395
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.943395
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.943395
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0188679	0.943395
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.943395
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.943395
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.943395
PALMOMENTAL REFLEX	0.0188679	0.943395
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.943395
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0188679	0.943395
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0188679	0.943395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	0.943395
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.0188679	0.943395
HYPERLIPOPROTEINEMIA, TYPE IV	0.0188679	0.943395
CERVICAL RIB	0.0188679	0.943395
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.943395
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.943395
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.943395
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.943395
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.0188679	0.943395
GLYCOGEN STORAGE DISEASE VI	0.0188679	0.943395
CARDIAC ARRHYTHMIA	0.0188679	0.943395
DIASTEMATOMYELIA	0.0188679	0.943395
GLYCOGEN STORAGE DISEASE IXA	0.0188679	0.943395
MOTION SICKNESS	0.0188679	0.943395
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.943395
ALCOHOL DEPENDENCE	0.0188679	0.943395
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0188679	0.943395
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.943395
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.943395
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.943395
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.943395
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.943395
269800 SENILE PLAQUE FORMATION	0.0188679	0.943395
ALAGILLE SYNDROME 1; ALGS1	0.0188679	0.943395
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.0188679	0.943395
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.943395
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.943395
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.943395
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.943395
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.943395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.018816523	0.9408261500000001
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.9393765000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.018777563	0.9388781500000001
Helsmoortel-van der Aa syndrome	0.018716123	0.9358061500000001
KOOLEN-DE VRIES SYNDROME; KDVS	0.018702193	0.9351096499999999
MUCOPOLYSACCHARIDOSIS, TYPE II	0.018654340999999998	0.9327170499999999
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.018654340999999998	0.9327170499999999
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.018654340999999998	0.9327170499999999
ZIMMERMANN-LABAND SYNDROME 1	0.018654340999999998	0.9327170499999999
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.018577043	0.9288521500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.018502320000000003	0.9251160000000002
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.018350882	0.9175441
ASPARTYLGLUCOSAMINURIA; AGU	0.018330681	0.9165340500000001
GAPO SYNDROME; GAPOS	0.018330681	0.9165340500000001
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.01832909	0.9164545
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.01832909	0.9164545
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.018290129999999998	0.9145064999999999
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.018203323	0.91016615
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.018203323	0.91016615
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.018203323	0.91016615
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.0181891	0.909455
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.018185751	0.9092875499999999
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.018181799999999998	0.90909
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.018181799999999998	0.90909
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.018181799999999998	0.90909
CHITAYAT SYNDROME	0.018181799999999998	0.90909
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.018181799999999998	0.90909
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.018181799999999998	0.90909
THREE M SYNDROME 2; 3M2	0.018181799999999998	0.90909
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 8; MGORS8	0.018181799999999998	0.90909
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.018164363000000003	0.9082181500000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018164363000000003	0.9082181500000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.018152302000000002	0.9076151000000001
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.018113881999999998	0.9056940999999998
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.018059000999999998	0.90295005
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.018059000999999998	0.90295005
OROFACIODIGITAL SYNDROME I; OFD1	0.018018051	0.90090255
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.017987132000000003	0.8993566000000002
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.017946181999999998	0.8973090999999999
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.017933681	0.89668405
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.017837463	0.8918731500000001
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.017825402	0.8912701000000001
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.017587743	0.87938715
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.017506381	0.8753190500000001
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.017506381	0.8753190500000001
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.017434512	0.8717256
COSTELLO SYNDROME; CSTLO	0.017434512	0.8717256
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.017359441000000003	0.8679720500000001
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01733349	0.8666745
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.017287572	0.8643786
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.017202732999999998	0.8601366499999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.017163773	0.85818865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.017144233000000002	0.8572116500000001
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.017144233000000002	0.8572116500000001
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01714325	0.8571624999999999
HOLOPROSENCEPHALY 2; HPE2	0.016998603	0.84993015
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.016956489999999998	0.8478244999999999
MEIER-GORLIN SYNDROME 3; MGORS3	0.016956489999999998	0.8478244999999999
PRIMROSE SYNDROME; PRIMS	0.01691753	0.8458765
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.01691753	0.8458765
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01691753	0.8458765
GAUCHER DISEASE, TYPE I	0.01688983	0.8444915000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.016836873	0.8418436499999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.016743861	0.83719305
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.016743861	0.83719305
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.016741282	0.8370641
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.01659063	0.8295315
CRI-DU-CHAT SYNDROME	0.01659063	0.8295315
#611554 LEOPARD SYNDROME 2	0.01659063	0.8295315
NOONAN SYNDROME 4; NS4	0.01659063	0.8295315
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.01659063	0.8295315
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.016578691	0.8289345499999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.8234441
ROIFMAN-CHITAYAT SYNDROME	0.016468882	0.8234441
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	0.8234441
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	0.8234441
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.016465533	0.82327665
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.016319891	0.81599455
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.016300351	0.8150175500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.016300351	0.8150175500000001
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.016267292000000003	0.8133646000000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.016252423000000002	0.8126211500000001
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.016252423000000002	0.8126211500000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.016213463	0.8106731500000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.016213463	0.8106731500000001
BARAITSER-WINTER SYNDROME 1; BRWS1	0.016140843000000002	0.8070421500000001
BOHRING-OPITZ SYNDROME	0.016009303	0.80046515
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.015975403	0.79877015
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.015682403	0.78412015
HYDROXYLYSINURIA	0.015625	0.78125
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	0.78125
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.78125
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.78125
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.78125
PAINE SYNDROME	0.015625	0.78125
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	0.78125
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.78125
CARNOSINEMIA	0.015625	0.78125
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.7810825499999999
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.015621650999999999	0.7810825499999999
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015621650999999999	0.7810825499999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.7810825499999999
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	0.7774891
GAUCHER DISEASE, TYPE II	0.015469932999999998	0.7734966499999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.015444863	0.77224315
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.015444863	0.77224315
PORPHYRIA VARIEGATA	0.0154431	0.7721549999999999
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.0154431	0.7721549999999999
VISCERAL MYOPATHY; VSCM	0.0154431	0.7721549999999999
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.0154431	0.7721549999999999
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.015403913	0.77019565
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.015384600000000002	0.7692300000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.015369581	0.76847905
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.015309221999999999	0.7654611
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.015193333	0.75966665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.015193333	0.75966665
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.015193333	0.75966665
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.015117963000000002	0.75589815
MENTAL RETARDATION, X-LINKED 9	0.015092933	0.75464665
RECOMBINANT CHROMOSOME 8 SYNDROME	0.015092933	0.75464665
#170100 PROLIDASE DEFICIENCY	0.015012622	0.7506311
Fabry disease	0.014964851	0.74824255
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.7352949999999999
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.7352949999999999
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.7352949999999999
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.7352949999999999
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.7352949999999999
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.7352949999999999
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.7352949999999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.7352949999999999
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.7352949999999999
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.7352949999999999
DYSTONIA 12; DYT12	0.0147059	0.7352949999999999
PSORIASIS 14, PUSTULAR	0.0147059	0.7352949999999999
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.0147059	0.7352949999999999
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.7352949999999999
NEUROPATHY, PAINFUL	0.0147059	0.7352949999999999
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.7352949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.7352949999999999
RHABDOMYOLYSIS, ACUTE RECURRENT	0.0147059	0.7352949999999999
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.7352949999999999
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.7352949999999999
CINCA SYNDROME; CINCA	0.0147059	0.7352949999999999
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.7352949999999999
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.7352949999999999
PANCREATITIS, HEREDITARY	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.7352949999999999
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.7352949999999999
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0147059	0.7352949999999999
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.7352949999999999
CAFFEY DISEASE	0.0147059	0.7352949999999999
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.7352949999999999
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01470487	0.7352435
COCKAYNE SYNDROME A; CSA	0.014687861	0.73439305
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.014687833	0.7343916500000001
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.014687833	0.7343916500000001
METHYLMALONIC ACIDURIA, CBLA TYPE	0.014687833	0.7343916500000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.014600981	0.7300490500000001
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.014580133000000002	0.7290066500000001
HYPEREKPLEXIA 4; HKPX4	0.014580133000000002	0.7290066500000001
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.014568072000000001	0.7284036
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.01445383	0.7226915
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.014349451	0.71747255
RENPENNING SYNDROME 1; RENS1	0.014274081000000001	0.71370405
FOUNTAIN SYNDROME	0.014249050999999999	0.71245255
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.014249050999999999	0.71245255
COFFIN-SIRIS SYNDROME 8; CSS8	0.014249050999999999	0.71245255
CLARK-BARAITSER SYNDROME	0.014249050999999999	0.71245255
ATKIN-FLAITZ SYNDROME	0.014249050999999999	0.71245255
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.014177182	0.7088591
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.014177182	0.7088591
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.014177182	0.7088591
ELSAHY-WATERS SYNDROME; ESWS	0.014177182	0.7088591
LISSENCEPHALY 3; LIS3	0.014106331	0.70531655
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0140491	0.702455
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.0140491	0.702455
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.014003513	0.70017565
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.014003513	0.70017565
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.014003513	0.70017565
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.013964553000000001	0.6982276500000001
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.013964553000000001	0.6982276500000001
LISSENCEPHALY 8; LIS8	0.013964553000000001	0.6982276500000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.013964553000000001	0.6982276500000001
MEHMO SYNDROME; MEHMO	0.013964553000000001	0.6982276500000001
MARSHALL-SMITH SYNDROME; MRSHSS	0.01384497	0.6922485
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.013843951	0.69219755
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.013772082000000001	0.6886041
METHYLMALONIC ACIDURIA, CBLB TYPE	0.013772082000000001	0.6886041
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013736251000000001	0.6868125500000001
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.013736251000000001	0.6868125500000001
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.013736251000000001	0.6868125500000001
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.013736251000000001	0.6868125500000001
CROME SYNDROME	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.013736251000000001	0.6868125500000001
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.013710300000000002	0.6855150000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.013664382000000003	0.6832191000000001
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013637653	0.6818826499999999
SCHAAF-YANG SYNDROME; SHFYNG	0.013579543	0.6789771499999999
Xq28 (MECP2) duplication	0.013540582999999998	0.67702915
611961 STEVENSON-CAREY SYNDROME	0.013540582999999998	0.67702915
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.013508982	0.6754490999999999
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.013508982	0.6754490999999999
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.013503883000000001	0.67519415
JOUBERT SYNDROME 14	0.013468032	0.6734015999999999
PREECLAMPSIA/ECLAMPSIA 1	0.013400291	0.67001455
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.013400291	0.67001455
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.013358330000000002	0.6679165
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.013358330000000002	0.6679165
OROFACIAL CLEFT 15	0.013358330000000002	0.6679165
MACS SYNDROME	0.0133333	0.666665
PROGNATHISM, MANDIBULAR	0.0133333	0.666665
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0133333	0.666665
MEIER-GORLIN SYNDROME 1; MGORS1	0.0133333	0.666665
MENTAL RETARDATION, X-LINKED 19	0.0133333	0.666665
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0133333	0.666665
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0133333	0.666665
CHIARI MALFORMATION TYPE II	0.01322954	0.661477
WIEDEMANN-STEINER SYNDROME; WDSTS	0.013213683	0.66068415
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.013159631	0.65798155
RETINITIS PIGMENTOSA 59; RP59	0.013159631	0.65798155
WARBURG MICRO SYNDROME 3; WARBM3	0.013120671	0.6560335500000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.013048802000000002	0.6524401000000001
TURNPENNY-FRY SYNDROME; TPFS	0.013048802	0.6524401
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.013048802	0.6524401
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.012944423	0.64722115
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.012944423	0.64722115
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.012944423	0.64722115
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.0129282	0.64641
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.012883513	0.64417565
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.012820500000000002	0.6410250000000001
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.012820500000000002	0.6410250000000001
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.012820500000000002	0.6410250000000001
IMMUNODEFICIENCY 44	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.012820500000000002	0.6410250000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.012820500000000002	0.6410250000000001
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.012820500000000002	0.6410250000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.012735660999999999	0.6367830499999999
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.012735660999999999	0.6367830499999999
RETT SYNDROME, CONGENITAL VARIANT	0.012696700999999998	0.6348350499999998
AU-KLINE SYNDROME; AUKS	0.012663792	0.6331896
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.012663792	0.6331896
COFFIN-SIRIS SYNDROME 7; CSS7	0.012663792	0.6331896
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.012663792	0.6331896
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.012629233	0.63146165
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.012629233	0.63146165
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012629233	0.63146165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.012629233	0.63146165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.012629233	0.63146165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.012629203	0.63146015
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.012629202999999999	0.6314601499999999
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.01260201	0.6301005000000001
Glycosylphosphatidylinositol biosynthesis defect 18	0.012520452999999999	0.6260226499999999
GALACTOSE EPIMERASE DEFICIENCY	0.012495552	0.6247776
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.012484539999999999	0.624227
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.012484539999999999	0.624227
ALPORT SYNDROME, X-LINKED; ATS	0.012484539999999999	0.624227
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.012484539999999999	0.624227
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.012484539999999999	0.624227
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.012484539999999999	0.624227
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.012425073	0.62125365
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.012425073	0.62125365
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.012386113	0.61930565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.012386113	0.61930565
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.012386113	0.61930565
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.012297932000000001	0.6148966
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.012224382999999998	0.6112191499999999
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.012204920000000001	0.6102460000000001
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.012100541	0.60502705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.012059213	0.60296065
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.012039631	0.60198155
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.011860633	0.59303165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.011860633	0.59303165
ADAMS-OLIVER SYNDROME 2; AOS2	0.011860633	0.59303165
GLASS SYNDROME	0.011860633	0.59303165
CORNELIA DE LANGE SYNDROME 3	0.011860633	0.59303165
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.011785351	0.58926755
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.011785351	0.58926755
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.011676570999999998	0.5838285499999999
HYPER-IGD SYNDROME	0.01165167	0.5825834999999999
HYPERLIPOPROTEINEMIA, TYPE I	0.01165167	0.5825834999999999
ARGININOSUCCINIC ACIDURIA	0.011570113	0.57850565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.011570113	0.57850565
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.011570113	0.57850565
CITRULLINEMIA, CLASSIC	0.011570113	0.57850565
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.011570113	0.57850565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.011570113	0.57850565
OCULOCEREBROCUTANEOUS SYNDROME	0.011542231	0.57711155
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.011542231	0.57711155
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.011542231	0.57711155
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.011542231	0.57711155
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.011531152999999999	0.5765576499999999
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.011531152999999999	0.5765576499999999
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.011470362000000001	0.5735181
CRANIOFRONTONASAL SYNDROME; CFNS	0.011470362	0.5735181
MICROPHTHALMIA, SYNDROMIC 3	0.011470362	0.5735181
MECKEL SYNDROME, TYPE 1; MKS1	0.011447539999999999	0.5723769999999999
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.011269792	0.5634896
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.011269792	0.5634896
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.011215331	0.56076655
MARDEN-WALKER SYNDROME	0.011215331	0.56076655
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.011215331	0.56076655
SICKLE CELL ANEMIA	0.011208010000000001	0.5604005000000001
TRIMETHYLAMINURIA	0.011208010000000001	0.5604005000000001
AMYLOIDOSIS, FAMILIAL VISCERAL	0.011208010000000001	0.5604005000000001
THROMBOCYTHEMIA, ESSENTIAL	0.011208010000000001	0.5604005000000001
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.011208010000000001	0.5604005000000001
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.011204252999999999	0.56021265
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.01118479	0.5592395
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.01118479	0.5592395
HARTSFIELD SYNDROME; HRTFDS	0.011143462	0.5571731
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.011143462	0.5571731
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.01112388	0.556194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.01112388	0.556194
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.01112388	0.556194
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.011064642999999999	0.5532321499999999
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.011016751	0.55083755
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.011016751	0.55083755
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011016751	0.55083755
GAUCHER DISEASE, PERINATAL LETHAL	0.011002861	0.55014305
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.011002861	0.55014305
DYSTONIA 28, CHILDHOOD-ONSET	0.010944882000000001	0.5472441
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.010944882000000001	0.5472441
NOONAN SYNDROME 11; NS11	0.010944882000000001	0.5472441
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.010944882000000001	0.5472441
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.010930992	0.5465496000000001
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.010930992	0.5465496000000001
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.010884350000000001	0.5442175
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.01086957	0.5434785
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.010726231	0.53631155
MAPLE SYRUP URINE DISEASE; MSUD	0.010726231	0.53631155
CYCLIC VOMITING SYNDROME	0.010726231	0.53631155
WARBURG MICRO SYNDROME 1	0.01062648	0.531324
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01046475	0.5232375
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01046475	0.5232375
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01046475	0.5232375
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010380323	0.51901615
GM2-GANGLIOSIDOSIS, AB VARIANT	0.010380323	0.51901615
CHROMOSOME 3q13.31 DELETION SYNDROME	0.01029958	0.514979
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01029958	0.514979
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01029958	0.514979
BAKER-GORDON SYNDROME; BAGOS	0.010288502	0.5144251
Myhre syndrome	0.010282571	0.51412855
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.010282571	0.51412855
SMITH-KINGSMORE SYNDROME; SKS	0.010220761	0.51103805
BARDET-BIEDL SYNDROME 1; BBS1	0.010210701999999999	0.5105350999999999
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.010148892	0.5074446
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.010101	0.50505
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.010101	0.50505
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.010101	0.50505
FACIAL ECTODERMAL DYSPLASIA	0.010101	0.50505
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.010101	0.50505
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.010101	0.50505
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.010101	0.50505
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.010101	0.50505
NOSE, ANOMALOUS SHAPE OF	0.010101	0.50505
RUIJS-AALFS SYNDROME; RJALS	0.010101	0.50505
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.010101	0.50505
BARBER-SAY SYNDROME; BBRSAY	0.010101	0.50505
OROFACIODIGITAL SYNDROME III	0.010101	0.50505
260150 PALANT CLEFT PALATE SYNDROME	0.010101	0.50505
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.010101	0.50505
15q26 overgrowth syndrome	0.010101	0.50505
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.010101	0.50505
VELOCARDIOFACIAL SYNDROME	0.010101	0.50505
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.010101	0.50505
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.010101	0.50505
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.01008711	0.5043555
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.01008711	0.5043555
SEA-BLUE HISTIOCYTE DISEASE	0.01008711	0.5043555
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.01008711	0.5043555
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.01008711	0.5043555
IMMUNODEFICIENCY 52; IMD52	0.01008711	0.5043555
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01008711	0.5043555
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.01008711	0.5043555
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.01008711	0.5043555
TRANSALDOLASE DEFICIENCY	0.01008711	0.5043555
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.01008711	0.5043555
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.01008711	0.5043555
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01008711	0.5043555
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.010060050000000001	0.5030025
SCALP-EAR-NIPPLE SYNDROME; SENS	0.010060050000000001	0.5030025
FOLATE MALABSORPTION, HEREDITARY	0.010005553	0.50027765
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.010005553	0.50027765
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.009956353	0.49781764999999994
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009956353	0.49781764999999994
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00981048	0.490524
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00981048	0.490524
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.009783032	0.4891516
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.009536441	0.47682205
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.009536441	0.47682205
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.009464572000000001	0.47322860000000005
HYPERMANGANESEMIA WITH DYSTONIA 2	0.009464572000000001	0.47322860000000005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.009464572000000001	0.47322860000000005
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.009464572000000001	0.47322860000000005
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.009464572000000001	0.47322860000000005
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.009464572000000001	0.47322860000000005
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.009425493	0.47127465
INFANTILE SIALIC ACID STORAGE DISEASE	0.009422253	0.47111265
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.009422253	0.47111265
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009305009999999999	0.46525049999999996
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.009161671	0.45808355
THYROCEREBRORETINAL SYNDROME	0.009161671	0.45808355
AUTISM, SUSCEPTIBILITY TO, 18	0.009112470999999999	0.45562354999999993
RETT SYNDROME; RTT	0.009112470999999999	0.45562354999999993
CHROMOSOME 10Q26 DELETION SYNDROME	0.009098593	0.45492965
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.009089802	0.45449009999999995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.009040602	0.4520301
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.009040602	0.4520301
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.009006013	0.45030065
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.009006013	0.45030065
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.009006013	0.45030065
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.009006013	0.45030065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.008967053	0.44835264999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.008967053	0.44835264999999996
ZTTK SYNDROME; ZTTKS	0.008967053	0.44835264999999996
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.008967053	0.44835264999999996
JACOBSEN SYNDROME	0.00893915	0.4469575
Diamond-Blackfan anemia 1	0.00893915	0.4469575
TEMTAMY SYNDROME; TEMTYS	0.008801883	0.44009415
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.008801883	0.44009415
HOLOPROSENCEPHALY 7	0.008801883	0.44009415
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.008801883	0.44009415
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.008801883	0.44009415
JABERI-ELAHI SYNDROME; JABELS	0.008801883	0.44009415
BAND HETEROTOPIA; BH	0.008801883	0.44009415
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.008801883	0.44009415
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008801883	0.44009415
VICI SYNDROME; VICIS	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.008801883	0.44009415
GABA-TRANSAMINASE DEFICIENCY	0.008801883	0.44009415
LISSENCEPHALY 4	0.008801883	0.44009415
HOLOPROSENCEPHALY 1; HPE1	0.008801883	0.44009415
PETERS-PLUS SYNDROME; PTRPLS	0.008801883	0.44009415
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.008801883	0.44009415
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.008729022999999999	0.43645114999999995
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.008640153	0.43200764999999997
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.008640153	0.43200764999999997
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.008640153	0.43200764999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.008640153	0.43200764999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00862069	0.4310345
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00862069	0.4310345
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.00862069	0.4310345
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.00862069	0.4310345
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.008601193	0.43005965
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.008601193	0.43005965
AL KAISSI SYNDROME; ALKAS	0.008601193	0.43005965
OCULOSKELETODENTAL SYNDROME; OCSKD	0.008506501999999999	0.42532509999999996
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.008506501999999999	0.42532509999999996
LYMPHEDEMA, HEREDITARY, III	0.008506501999999999	0.42532509999999996
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00848692	0.424346
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00848692	0.424346
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00848692	0.424346
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.008405362999999999	0.42026814999999995
SALLA DISEASE	0.008405362999999999	0.42026814999999995
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.008405362999999999	0.42026814999999995
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.008405362999999999	0.42026814999999995
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00824592	0.412296
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.00824592	0.412296
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.409836
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	0.409836
MYXEDEMA	0.00819672	0.409836
UROFACIAL SYNDROME 2	0.00819672	0.409836
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	0.409836
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.409836
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	0.409836
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.409836
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	0.409836
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00819672	0.409836
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.409836
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	0.409836
UROFACIAL SYNDROME	0.00819672	0.409836
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	0.409836
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	0.409836
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	0.409836
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.409836
ANAL SPHINCTER DYSPLASIA; ASDP	0.00819672	0.409836
ADIPOSIS DOLOROSA	0.00819672	0.409836
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.409836
FG SYNDROME 2; FGS2	0.00819672	0.409836
PAPILLOMA OF CHOROID PLEXUS	0.008162131	0.40810654999999996
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.008162131	0.40810654999999996
EPISODIC ATAXIA, TYPE 6	0.008162131	0.40810654999999996
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.008162131	0.40810654999999996
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.008162131	0.40810654999999996
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.008162131	0.40810654999999996
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.008123171	0.40615855
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.008123171	0.40615855
TYSHCHENKO SYNDROME	0.008051302	0.4025651
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.008051302	0.4025651
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.007958001	0.39790004999999995
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007958001	0.39790004999999995
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.007958001	0.39790004999999995
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.007958001	0.39790004999999995
BARAITSER-WINTER SYNDROME 2; BRWS2	0.007958001	0.39790004999999995
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.007958001	0.39790004999999995
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.007958001	0.39790004999999995
FRYNS SYNDROME; FRNS	0.007958001	0.39790004999999995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.007946923	0.39734615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007946923	0.39734615
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.007946923	0.39734615
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.007946923	0.39734615
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.007907963	0.39539815
MENTAL RETARDATION, X-LINKED 104; MRX104	0.007907963	0.39539815
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.007907963	0.39539815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.007907963	0.39539815
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.007886132	0.3943066
HOLOPROSENCEPHALY 11	0.007886132	0.3943066
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.007886132	0.3943066
SEPTOOPTIC DYSPLASIA	0.007886132	0.3943066
CRANIOSYNOSTOSIS 6; CRS6	0.007886132	0.3943066
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007886132	0.3943066
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.007886132	0.3943066
CURRY-JONES SYNDROME	0.007886132	0.3943066
GENITOPATELLAR SYNDROME; GTPTS	0.007886132	0.3943066
CRANIOTELENCEPHALIC DYSPLASIA	0.007886132	0.3943066
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.007886132	0.3943066
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.007886132	0.3943066
PALLISTER-KILLIAN SYNDROME	0.0077962710000000005	0.38981355
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.007757311	0.38786555
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.007757311	0.38786555
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.007757311	0.38786555
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.007724402	0.3862201
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.007724402	0.3862201
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007724402	0.3862201
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.007724402	0.3862201
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007724402	0.3862201
Mental retardation, autosomal dominant 21	0.007724402	0.3862201
CHROMOSOME 17P13.1 DELETION SYNDROME	0.007724402	0.3862201
KEUTEL SYNDROME; KTLS	0.007718471	0.38592355
SNEDDON SYNDROME	0.007718471	0.38592355
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.38592355
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.007718471	0.38592355
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.007718471	0.38592355
NEUROFIBROMATOSIS, TYPE I	0.007718471	0.38592355
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00770482	0.385241
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00770482	0.385241
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.007685442	0.3842721
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00766262	0.383131
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00766262	0.383131
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00766262	0.383131
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.007581063	0.37905315
REVESZ SYNDROME	0.007489612	0.3744806
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.007441453	0.37207265
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.007441453	0.37207265
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007441453	0.37207265
MIRAGE SYNDROME; MIRAGE	0.007441453	0.37207265
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00733896	0.366948
EHLERS-DANLOS SYNDROME, TYPE VI	0.00733896	0.366948
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00724638	0.362319
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.362319
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.362319
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.362319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.362319
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00724638	0.362319
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.362319
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.362319
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.362319
VALINEMIA	0.00724638	0.362319
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.362319
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00724638	0.362319
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.362319
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.362319
EPISODIC ATAXIA, TYPE 3	0.00724638	0.362319
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.362319
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00724638	0.362319
CHYLOMICRON RETENTION DISEASE	0.00724638	0.362319
LIVER FAILURE, INFANTILE, TRANSIENT	0.00724638	0.362319
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00724638	0.362319
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.362319
GALACTOSEMIA	0.00724638	0.362319
LESCH-NYHAN SYNDROME; LNS	0.00724638	0.362319
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.362319
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.362319
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.362319
PORPHYRIA, ACUTE HEPATIC	0.00724638	0.362319
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.362319
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00724638	0.362319
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.362319
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.362319
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00724638	0.362319
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.362319
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.362319
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.362319
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.362319
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00724638	0.362319
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00720742	0.360371
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00720742	0.360371
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00720742	0.360371
FONTAINE PROGEROID SYNDROME; FPS	0.00720742	0.360371
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00704225	0.3521125
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00704225	0.3521125
MECKEL SYNDROME 12; MKS12	0.00704225	0.3521125
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00704225	0.3521125
PSEUDOTRISOMY 13 SYNDROME	0.00704225	0.3521125
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.3521125
MASA SYNDROME	0.00704225	0.3521125
HEMIFACIAL MICROSOMIA	0.00704225	0.3521125
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00704225	0.3521125
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00704225	0.3521125
SCHIZENCEPHALY	0.00704225	0.3521125
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00704225	0.3521125
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00704225	0.3521125
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00704225	0.3521125
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00704225	0.3521125
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.3521125
FETAL AKINESIA SYNDROME, X-LINKED	0.00704225	0.3521125
AGNATHIA-OTOCEPHALY COMPLEX	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME XV; OFD15	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME V; OFD5	0.00704225	0.3521125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00704225	0.3521125
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00704225	0.3521125
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00704225	0.3521125
STROMME SYNDROME; STROMS	0.00704225	0.3521125
HYDROLETHALUS SYNDROME 1	0.00704225	0.3521125
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00704225	0.3521125
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00704225	0.3521125
FOCAL DERMAL HYPOPLASIA; FDH	0.00704225	0.3521125
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00704225	0.3521125
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00704225	0.3521125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.007031172	0.3515586
JOUBERT SYNDROME 21	0.006992211999999999	0.3496106
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006992211999999999	0.3496106
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00696939	0.3484695
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00696939	0.3484695
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00688052	0.344026
Mulchandani-Bhoj-Conlin syndrome	0.00688052	0.344026
CEREBROOCULONASAL SYNDROME	0.00684156	0.342078
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.340136
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.340136
Paragangliomas 6	0.00680272	0.340136
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.340136
ROWLEY-ROSENBERG SYNDROME	0.00680272	0.340136
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.00680272	0.340136
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00680272	0.340136
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00680272	0.340136
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00680272	0.340136
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 2	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00680272	0.340136
XFE PROGEROID SYNDROME; XFEPS	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00680272	0.340136
POLYCYSTIC KIDNEYS	0.00680272	0.340136
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00680272	0.340136
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00680272	0.340136
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.00680272	0.340136
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.340136
HUNTER-MACDONALD SYNDROME	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 3	0.00680272	0.340136
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.340136
ALAGILLE SYNDROME 2	0.00680272	0.340136
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	0.340136
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.340136
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00680272	0.340136
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.340136
ARTERIAL TORTUOSITY SYNDROME	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00680272	0.340136
NEPHRONOPHTHISIS 1	0.00680272	0.340136
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.340136
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.00680272	0.340136
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00680272	0.340136
LIDDLE SYNDROME 1; LIDLS1	0.00680272	0.340136
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.340136
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00680272	0.340136
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00680272	0.340136
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00680272	0.340136
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.340136
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.340136
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00680272	0.340136
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IA	0.00680272	0.340136
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00680272	0.340136
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00680272	0.340136
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.340136
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.340136
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IB	0.00680272	0.340136
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00680272	0.340136
SECKEL SYNDROME 10; SCKL10	0.00680272	0.340136
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00680272	0.340136
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.340136
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00680272	0.340136
LONG QT SYNDROME 13; LQT13	0.00680272	0.340136
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.340136
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.006737181	0.33685905
JOUBERT SYNDROME 1	0.006665312	0.3332656
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.006665312	0.3332656
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00664573	0.3322865
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00664573	0.3322865
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00664573	0.3322865
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00664573	0.3322865
CEREBELLOPARENCHYMAL DISORDER V	0.00664573	0.3322865
CORNELIA DE LANGE SYNDROME 1	0.006597571	0.32987855
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.006597571	0.32987855
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.006597571	0.32987855
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.006597571	0.32987855
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.006597571	0.32987855
PSEUDO-TORCH SYNDROME 2	0.006597571	0.32987855
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0065257019999999995	0.3262851
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0065257019999999995	0.3262851
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0065257019999999995	0.3262851
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0065257019999999995	0.3262851
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0065257019999999995	0.3262851
FORSYTHE-WAKELING SYNDROME; FWS	0.0065257019999999995	0.3262851
LIG4 SYNDROME	0.0065257019999999995	0.3262851
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.006164923	0.30824615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.006164923	0.30824615
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00614833	0.3074165
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.005841263	0.29206315
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.005841263	0.29206315
JOUBERT SYNDROME 3; JBTS3	0.00582143	0.2910715
FECHTNER SYNDROME	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.284091
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.284091
BEEMER LETHAL MALFORMATION SYNDROME	0.00568182	0.284091
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.00568182	0.284091
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00568182	0.284091
SEBASTIAN SYNDROME	0.00568182	0.284091
THROMBOCYTOPENIA 3	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.284091
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.00568182	0.284091
PLATELET DISORDER, UNDEFINED	0.00568182	0.284091
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00568182	0.284091
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00568182	0.284091
IVIC SYNDROME	0.00568182	0.284091
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.00568182	0.284091
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00568182	0.284091
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.00568182	0.284091
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.00568182	0.284091
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.284091
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.00568182	0.284091
THROMBOCYTOPENIA, CYCLIC	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00568182	0.284091
Bernard-Soulier syndrome	0.00568182	0.284091
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00568182	0.284091
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.00568182	0.284091
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.284091
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00568182	0.284091
NIJMEGEN BREAKAGE SYNDROME	0.00568182	0.284091
THROMBOCYTOPENIA 5; THC5	0.00568182	0.284091
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00568182	0.284091
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00568182	0.284091
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00568182	0.284091
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.284091
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.284091
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.00568182	0.284091
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00568182	0.284091
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00568182	0.284091
FANCONI ANEMIA	0.00568182	0.284091
EOSINOPHILIA, FAMILIAL	0.00568182	0.284091
STORMORKEN SYNDROME; STRMK	0.00568182	0.284091
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00568182	0.284091
MONOSOMY 7 OF BONE MARROW	0.00568182	0.284091
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.284091
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.284091
THROMBOCYTOPENIA 6	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.284091
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.284091
WT LIMB-BLOOD SYNDROME	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.284091
DK PHOCOMELIA SYNDROME	0.00568182	0.284091
THROMBOCYTOPENIA 2	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00568182	0.284091
SENGERS SYNDROME	0.00568182	0.284091
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.284091
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.005382823	0.26914115
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.005382823	0.26914115
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.005382823	0.26914115
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.005382823	0.26914115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.005382823	0.26914115
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005382823	0.26914115
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005382823	0.26914115
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.005382823	0.26914115
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005382823	0.26914115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.005382823	0.26914115
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.005382823	0.26914115
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.005382823	0.26914115
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.005382823	0.26914115
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.005382823	0.26914115
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.005382823	0.26914115
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005382823	0.26914115
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.005382823	0.26914115
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.005382823	0.26914115
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.005382823	0.26914115
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.005382823	0.26914115
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.005382823	0.26914115
Pierpont syndrome	0.005382823	0.26914115
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.005382823	0.26914115
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.005382823	0.26914115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005382823	0.26914115
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.005382823	0.26914115
WIEACKER-WOLFF SYNDROME	0.005382823	0.26914115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005382823	0.26914115
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.005382823	0.26914115
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.005343863	0.26719315
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005343863	0.26719315
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.005343863	0.26719315
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005343863	0.26719315
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.005343863	0.26719315
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.005343863	0.26719315
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.005343863	0.26719315
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005343863	0.26719315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.005343863	0.26719315
CODAS SYNDROME	0.005343863	0.26719315
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.005343863	0.26719315
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005343863	0.26719315
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005343863	0.26719315
NEURAMINIDASE DEFICIENCY	0.005321041	0.26605205000000004
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.005321041	0.26605205000000004
ADAMS-OLIVER SYNDROME 5; AOS5	0.005321041	0.26605205000000004
IMMUNODEFICIENCY 47	0.005321041	0.26605205000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005321041	0.26605205000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005321041	0.26605205000000004
GAUCHER DISEASE, TYPE IIIC	0.005321041	0.26605205000000004
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.005321041	0.26605205000000004
ROIFMAN SYNDROME; RFMN	0.005249172	0.2624586
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.005249172	0.2624586
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.005249172	0.2624586
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.005249172	0.2624586
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.005249172	0.2624586
MACROCEPHALY/AUTISM SYNDROME	0.005249172	0.2624586
#300867 KABUKI SYNDROME 2; KABUK2	0.005016963	0.25084815
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.005016963	0.25084815
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.005016963	0.25084815
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.005016963	0.25084815
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.005016963	0.25084815
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.005016963	0.25084815
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.005016963	0.25084815
OCULOECTODERMAL SYNDROME; OES	0.005016963	0.25084815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005016963	0.25084815
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005016963	0.25084815
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.005016963	0.25084815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005016963	0.25084815
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.005016963	0.25084815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005016963	0.25084815
MENTAL RETARDATION, X-LINKED 91; MRX91	0.005016963	0.25084815
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.005016963	0.25084815
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.005016963	0.25084815
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005016963	0.25084815
WEAVER SYNDROME	0.005016963	0.25084815
C SYNDROME	0.005016963	0.25084815
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.24986905
XYLOSIDASE DEFICIENCY	0.004997381	0.24986905
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.004997381	0.24986905
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004997381	0.24986905
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.24986905
EPILEPSY-TELANGIECTASIA	0.004997381	0.24986905
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.24986905
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004997381	0.24986905
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.24627559999999998
LARSEN-LIKE SYNDROME	0.004925512	0.24627559999999998
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.004538941	0.22694705
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004538941	0.22694705
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.004538941	0.22694705
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.004538941	0.22694705
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.004538941	0.22694705
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.004538941	0.22694705
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.004538941	0.22694705
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.004538941	0.22694705
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004499981	0.22499905
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004499981	0.22499905
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004499981	0.22499905
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.004499981	0.22499905
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.004499981	0.22499905
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004499981	0.22499905
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004499981	0.22499905
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.004499981	0.22499905
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.004499981	0.22499905
MENTAL RETARDATION, X-LINKED 102	0.004499981	0.22499905
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004499981	0.22499905
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.004499981	0.22499905
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004499981	0.22499905
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004499981	0.22499905
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.004467072	0.22335359999999999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.004467072	0.22335359999999999
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.004467072	0.22335359999999999
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004467072	0.22335359999999999
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004467072	0.22335359999999999
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.004467072	0.22335359999999999
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.004467072	0.22335359999999999
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.004467072	0.22335359999999999
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.004467072	0.22335359999999999
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.004467072	0.22335359999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.004467072	0.22335359999999999
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004467072	0.22335359999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004467072	0.22335359999999999
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.004467072	0.22335359999999999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004428112	0.22140559999999998
XIA-GIBBS SYNDROME	0.004428112	0.22140559999999998
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004428112	0.22140559999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004428112	0.22140559999999998
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004428112	0.22140559999999998
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.004428112	0.22140559999999998
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.004428112	0.22140559999999998
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004428112	0.22140559999999998
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.004428112	0.22140559999999998
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.004428112	0.22140559999999998
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004428112	0.22140559999999998
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.004428112	0.22140559999999998
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004428112	0.22140559999999998
JOUBERT SYNDROME 31; JBTS31	0.004428112	0.22140559999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004428112	0.22140559999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.004428112	0.22140559999999998
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.004428112	0.22140559999999998
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.004428112	0.22140559999999998
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.004428112	0.22140559999999998
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00440529	0.2202645
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00440529	0.2202645
IMMUNODEFICIENCY 60; IMD60	0.00440529	0.2202645
ELLIPTOCYTOSIS 1; EL1	0.00440529	0.2202645
NEPHRONOPHTHISIS 19; NPHP19	0.00440529	0.2202645
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00440529	0.2202645
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2A	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00440529	0.2202645
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00440529	0.2202645
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00440529	0.2202645
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00440529	0.2202645
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00440529	0.2202645
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00440529	0.2202645
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2B	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00440529	0.2202645
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00440529	0.2202645
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00440529	0.2202645
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00440529	0.2202645
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00440529	0.2202645
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.00440529	0.2202645
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00440529	0.2202645
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00440529	0.2202645
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00440529	0.2202645
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00440529	0.2202645
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00440529	0.2202645
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00440529	0.2202645
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00440529	0.2202645
IMMUNODEFICIENCY 16	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00440529	0.2202645
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 1	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 2	0.00440529	0.2202645
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00440529	0.2202645
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00440529	0.2202645
FELTY SYNDROME	0.00440529	0.2202645
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00440529	0.2202645
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00440529	0.2202645
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00440529	0.2202645
TYROSINEMIA, TYPE I; TYRSN1	0.00440529	0.2202645
CASPASE 8 DEFICIENCY	0.00440529	0.2202645
PROTEUS SYNDROME	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00440529	0.2202645
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00440529	0.2202645
HEMOGLOBIN--BETA LOCUS	0.00440529	0.2202645
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00440529	0.2202645
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.2202645
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00440529	0.2202645
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 1; SPH1	0.00440529	0.2202645
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00440529	0.2202645
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00440529	0.2202645
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00440529	0.2202645
HYPERLIPOPROTEINEMIA, TYPE ID	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00440529	0.2202645
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00440529	0.2202645
GLYCOPROTEIN STORAGE DISEASE	0.00440529	0.2202645
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00440529	0.2202645
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00440529	0.2202645
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00440529	0.2202645
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00440529	0.2202645
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.00440529	0.2202645
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00440529	0.2202645
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00440529	0.2202645
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00440529	0.2202645
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00440529	0.2202645
REYNOLDS SYNDROME	0.00440529	0.2202645
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.004323733	0.21618664999999998
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.004323733	0.21618664999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004323733	0.21618664999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.004323733	0.21618664999999998
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.004323733	0.21618664999999998
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.004323733	0.21618664999999998
ELEJALDE DISEASE	0.004323733	0.21618664999999998
Cerebral creatine deficiency syndrome 2	0.004323733	0.21618664999999998
CHROMOSOME 1p35 DELETION SYNDROME	0.004323733	0.21618664999999998
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.004323733	0.21618664999999998
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.004323733	0.21618664999999998
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.004323733	0.21618664999999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.004323733	0.21618664999999998
PELIZAEUS-MERZBACHER DISEASE	0.004323733	0.21618664999999998
SULFOCYSTEINURIA	0.004323733	0.21618664999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004323733	0.21618664999999998
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004323733	0.21618664999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004323733	0.21618664999999998
LEIGH SYNDROME; LS	0.004323733	0.21618664999999998
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.004323733	0.21618664999999998
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.004323733	0.21618664999999998
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.004323733	0.21618664999999998
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.004323733	0.21618664999999998
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.004323733	0.21618664999999998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004323733	0.21618664999999998
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.004323733	0.21618664999999998
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.004173081	0.20865405
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.004173081	0.20865405
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004173081	0.20865405
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.004173081	0.20865405
POTOCKI-SHAFFER SYNDROME	0.004173081	0.20865405
MECKEL SYNDROME, TYPE 10; MKS10	0.004173081	0.20865405
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004173081	0.20865405
OHDO SYNDROME	0.004173081	0.20865405
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.004173081	0.20865405
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.004101212	0.20506059999999998
OROFACIODIGITAL SYNDROME VI	0.004101212	0.20506059999999998
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.004101212	0.20506059999999998
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.004101212	0.20506059999999998
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.004101212	0.20506059999999998
BARATELA-SCOTT SYNDROME	0.004101212	0.20506059999999998
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004101212	0.20506059999999998
NOONAN SYNDROME 3; NS3	0.004101212	0.20506059999999998
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004101212	0.20506059999999998
CHROMOSOME 9P DELETION SYNDROME	0.004101212	0.20506059999999998
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.004101212	0.20506059999999998
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.004101212	0.20506059999999998
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004101212	0.20506059999999998
FRONTOOCULAR SYNDROME	0.004101212	0.20506059999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004101212	0.20506059999999998
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.004101212	0.20506059999999998
CHROMOSOME 16Q22 DELETION SYNDROME	0.004101212	0.20506059999999998
#614976 CARPENTER SYNDROME 2; CRPT2	0.004101212	0.20506059999999998
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004101212	0.20506059999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.004101212	0.20506059999999998
NOONAN SYNDROME 6; NS6	0.004101212	0.20506059999999998
WARSAW BREAKAGE SYNDROME; WABS	0.004101212	0.20506059999999998
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.004101212	0.20506059999999998
DESBUQUOIS DYSPLASIA 2; DBQD2	0.004101212	0.20506059999999998
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.004101212	0.20506059999999998
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004101212	0.20506059999999998
DIAPHANOSPONDYLODYSOSTOSIS	0.004101212	0.20506059999999998
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.004101212	0.20506059999999998
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.2040815
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.2040815
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.2040815
APOLIPOPROTEIN(A)	0.00408163	0.2040815
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.2040815
GLOMUVENOUS MALFORMATIONS	0.00408163	0.2040815
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.2040815
PREMATURE OVARIAN FAILURE 1	0.00408163	0.2040815
GLUTATHIONURIA	0.00408163	0.2040815
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.2040815
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.2040815
ALKAPTONURIA	0.00408163	0.2040815
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.2040815
DERMATOLEUKODYSTROPHY	0.00408163	0.2040815
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.2040815
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.2040815
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.2040815
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.2040815
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.2040815
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.2040815
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.2040815
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.2040815
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.2040815
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.2040815
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.2040815
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.2040815
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.2040815
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.2040815
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.2040815
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.2040815
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.2040815
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.2040815
ZINC, ELEVATED PLASMA	0.00408163	0.2040815
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.2040815
LARON SYNDROME	0.00408163	0.2040815
LYMPHOKINE DEFICIENCY	0.00408163	0.2040815
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.2040815
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.2040815
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.2040815
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.2040815
DERMATITIS, ATOPIC	0.00408163	0.2040815
GLUTATHIONE REDUCTASE	0.00408163	0.2040815
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.2040815
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.2040815
ETHANOLAMINOSIS	0.00408163	0.2040815
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.2040815
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.2040815
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.2040815
T-SUBSTANCE ANOMALY	0.00408163	0.2040815
ALAND ISLAND EYE DISEASE	0.00408163	0.2040815
PERRY SYNDROME	0.00408163	0.2040815
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.2040815
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.2040815
CALVARIAL HYPEROSTOSIS	0.00408163	0.2040815
PENDRED SYNDROME	0.00408163	0.2040815
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.2040815
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.2040815
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.2040815
ICHTHYOSIS, X-LINKED	0.00408163	0.2040815
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.2040815
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.2040815
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.2040815
OVARIAN CANCER	0.00408163	0.2040815
PYGMY	0.00408163	0.2040815
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.2040815
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.2040815
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.2040815
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.2040815
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.2040815
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.2040815
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.2040815
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.2040815
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.2040815
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.2040815
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.2040815
AREDYLD	0.00408163	0.2040815
BEETURIA	0.00408163	0.2040815
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.2040815
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.2040815
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.2040815
NEPHROSIALIDOSIS	0.00408163	0.2040815
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.2040815
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.2040815
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.2040815
ACETYLATION, SLOW	0.00408163	0.2040815
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.2040815
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.2040815
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.2040815
CITRULLINE TRANSPORT DEFECT	0.00408163	0.2040815
ONCOCYTOMA	0.00408163	0.2040815
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.2040815
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.2040815
CARBOXYLESTERASE 1	0.00408163	0.2040815
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.2040815
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.2040815
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.2040815
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.2040815
TRISOMY 18-LIKE SYNDROME	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.2040815
LIPASE DEFICIENCY, COMBINED	0.00408163	0.2040815
MYOPATHY, SPHEROID BODY	0.00408163	0.2040815
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.2040815
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.2040815
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.2040815
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.2040815
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.2040815
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.2040815
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.2040815
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.2040815
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.2040815
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.2040815
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.2040815
XANTHINURIA, TYPE I	0.00408163	0.2040815
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.2040815
HYPERPROGLUCAGONEMIA	0.00408163	0.2040815
PARAOXONASE 1	0.00408163	0.2040815
SPINAL ARACHNOIDITIS	0.00408163	0.2040815
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.2040815
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.2040815
PITUITARY DWARFISM IV	0.00408163	0.2040815
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.2040815
SCHIZOPHRENIA 4	0.00408163	0.2040815
OSTEOGENIC SARCOMA	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.2040815
FINGERPRINT BODY MYOPATHY	0.00408163	0.2040815
XM SYSTEM	0.00408163	0.2040815
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.2040815
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.2040815
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.2040815
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.2040815
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.2040815
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.2040815
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.2040815
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.2040815
PROGESTERONE RESISTANCE	0.00408163	0.2040815
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.2040815
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.2040815
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.2040815
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.2040815
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.2040815
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.2040815
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.2040815
HEINZ BODY ANEMIAS	0.00408163	0.2040815
GONADOBLASTOMA	0.00408163	0.2040815
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.2040815
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.2040815
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.2040815
DELETED IN AZOOSPERMIA	0.00408163	0.2040815
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.2040815
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.2040815
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.2040815
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.2040815
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.2040815
PACMAN DYSPLASIA	0.00408163	0.2040815
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.2040815
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.2040815
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.2040815
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.2040815
HOOFT DISEASE	0.00408163	0.2040815
HYPOASCORBEMIA	0.00408163	0.2040815
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.2040815
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00362319	0.1811595
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00362319	0.1811595
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00362319	0.1811595
NEMALINE MYOPATHY 2; NEM2	0.00362319	0.1811595
MEIER-GORLIN SYNDROME 2; MGORS2	0.00362319	0.1811595
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00362319	0.1811595
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00362319	0.1811595
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00362319	0.1811595
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00362319	0.1811595
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00362319	0.1811595
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00362319	0.1811595
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00362319	0.1811595
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00362319	0.1811595
CHARGE SYNDROME	0.00362319	0.1811595
#168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC;;PARALYSIS PERIODICA PARAMYOTONICAPARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED	0.00362319	0.1811595
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00362319	0.1811595
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00362319	0.1811595
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00362319	0.1811595
PEROXISOME BIOGENESIS DISORDER 11B	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00362319	0.1811595
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00362319	0.1811595
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00358423	0.1792115
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00358423	0.1792115
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00358423	0.1792115
FRONTONASAL DYSPLASIA 2; FND2	0.00358423	0.1792115
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00358423	0.1792115
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00358423	0.1792115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00358423	0.1792115
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00358423	0.1792115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00358423	0.1792115
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00358423	0.1792115
MECKEL SYNDROME, TYPE 4; MKS4	0.00358423	0.1792115
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00358423	0.1792115
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00358423	0.1792115
ANIRIDIA	0.00358423	0.1792115
DIAMINOPENTANURIA	0.003479851	0.17399255
FLYNN-AIRD SYNDROME	0.003479851	0.17399255
KNOBLOCH SYNDROME 1; KNO1	0.003479851	0.17399255
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.003479851	0.17399255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.003479851	0.17399255
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.003479851	0.17399255
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.003479851	0.17399255
NEUROFIBROMATOSIS, TYPE II	0.003479851	0.17399255
CEREBELLOPARENCHYMAL DISORDER II	0.003479851	0.17399255
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.003479851	0.17399255
KUFOR-RAKEB SYNDROME	0.003479851	0.17399255
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.003479851	0.17399255
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.003479851	0.17399255
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003479851	0.17399255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.003479851	0.17399255
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.003479851	0.17399255
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.003479851	0.17399255
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.003479851	0.17399255
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.003479851	0.17399255
GLUTATHIONE SYNTHETASE DEFICIENCY	0.003479851	0.17399255
KEARNS-SAYRE SYNDROME; KSS	0.003479851	0.17399255
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.003479851	0.17399255
PERRAULT SYNDROME 5; PRLTS5	0.003479851	0.17399255
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.003479851	0.17399255
ALEXANDER DISEASE	0.003479851	0.17399255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 33; JBTS33	0.0034079819999999995	0.17039909999999997
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 8	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 6	0.0034079819999999995	0.17039909999999997
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0034079819999999995	0.17039909999999997
RICHARDS-RUNDLE SYNDROME; RRNS	0.0034079819999999995	0.17039909999999997
MECKEL SYNDROME 13; MKS13	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 35; JBTS35	0.0034079819999999995	0.17039909999999997
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0034079819999999995	0.17039909999999997
PELLAGRA-LIKE SYNDROME	0.0034079819999999995	0.17039909999999997
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0034079819999999995	0.17039909999999997
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0034079819999999995	0.17039909999999997
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 25	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 32; JBTS32	0.0034079819999999995	0.17039909999999997
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0034079819999999995	0.17039909999999997
WAARDENBURG-SHAH SYNDROME	0.0034079819999999995	0.17039909999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0034079819999999995	0.17039909999999997
IMMUNODEFICIENCY 23; IMD23	0.0034079819999999995	0.17039909999999997
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0034079819999999995	0.17039909999999997
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0034079819999999995	0.17039909999999997
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0034079819999999995	0.17039909999999997
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0034079819999999995	0.17039909999999997
ARIMA SYNDROME	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 17; JBTS17	0.0034079819999999995	0.17039909999999997
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0034079819999999995	0.17039909999999997
MARINESCO-SJOGREN SYNDROME; MSS	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 15	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 27	0.0034079819999999995	0.17039909999999997
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0034079819999999995	0.17039909999999997
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0034079819999999995	0.17039909999999997
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0034079819999999995	0.17039909999999997
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 28	0.0034079819999999995	0.17039909999999997
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00325733	0.1628665
DUANE-RADIAL RAY SYNDROME; DRRS	0.00325733	0.1628665
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00325733	0.1628665
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00325733	0.1628665
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00325733	0.1628665
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00325733	0.1628665
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00325733	0.1628665
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00325733	0.1628665
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00325733	0.1628665
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00325733	0.1628665
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00325733	0.1628665
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00325733	0.1628665
EPICANTHUS	0.00325733	0.1628665
PTERYGIUM COLLI, ISOLATED	0.00325733	0.1628665
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00325733	0.1628665
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00325733	0.1628665
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00325733	0.1628665
OMODYSPLASIA 1; OMOD1	0.00325733	0.1628665
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00325733	0.1628665
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00325733	0.1628665
SCHOLTE SYNDROME; SHLTS	0.00325733	0.1628665
#278250 WRINKLY SKIN SYNDROME; WSS	0.00325733	0.1628665
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00325733	0.1628665
LICHTENSTEIN SYNDROME	0.00325733	0.1628665
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00325733	0.1628665
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00325733	0.1628665
COFFIN-SIRIS SYNDROME 10; CSS10	0.00325733	0.1628665
CRANIOECTODERMAL DYSPLASIA 1	0.00325733	0.1628665
600736 VELOFACIOSKELETAL SYNDROME	0.00325733	0.1628665
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00325733	0.1628665
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00325733	0.1628665
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00325733	0.1628665
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00325733	0.1628665
MARTSOLF SYNDROME	0.00325733	0.1628665
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00325733	0.1628665
MEGAEPIPHYSEAL DWARFISM	0.00325733	0.1628665
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00325733	0.1628665
SIFRIM-HITZ-WEISS SYNDROME	0.00325733	0.1628665
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00325733	0.1628665
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00325733	0.1628665
PFEIFFER-PALM-TELLER SYNDROME	0.00325733	0.1628665
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00325733	0.1628665
BRITTLE CORNEA SYNDROME	0.00325733	0.1628665
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00325733	0.1628665
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00325733	0.1628665
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00325733	0.1628665
SCARF SYNDROME	0.00325733	0.1628665
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00325733	0.1628665
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00325733	0.1628665
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00325733	0.1628665
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00325733	0.1628665
OROFACIODIGITAL SYNDROME IV; OFD4	0.00325733	0.1628665
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00325733	0.1628665
HYPOGLOSSIA-HYPODACTYLIA	0.00325733	0.1628665
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00325733	0.1628665
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00325733	0.1628665
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00325733	0.1628665
NOONAN SYNDROME 8; NS8	0.00325733	0.1628665
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00325733	0.1628665
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00325733	0.1628665
EHLERS-DANLOS SYNDROME, TYPE I	0.00325733	0.1628665
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00325733	0.1628665
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00325733	0.1628665
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00325733	0.1628665
LEGIUS SYNDROME	0.00325733	0.1628665
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00325733	0.1628665
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0025640999999999997	0.12820499999999999
ATAXIA WITH FASCICULATIONS	0.0025640999999999997	0.12820499999999999
POLYMYOCLONUS, INFANTILE	0.0025640999999999997	0.12820499999999999
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0025640999999999997	0.12820499999999999
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0025640999999999997	0.12820499999999999
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0025640999999999997	0.12820499999999999
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0025640999999999997	0.12820499999999999
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0025640999999999997	0.12820499999999999
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.0025640999999999997	0.12820499999999999
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0025640999999999997	0.12820499999999999
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0025640999999999997	0.12820499999999999
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0025640999999999997	0.12820499999999999
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0025640999999999997	0.12820499999999999
REFSUM DISEASE	0.0025640999999999997	0.12820499999999999
Boucher-Neuhauser syndrome	0.0025640999999999997	0.12820499999999999
POSTERIOR COLUMN ATAXIA	0.0025640999999999997	0.12820499999999999
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0025640999999999997	0.12820499999999999
#276880 UROCANASE DEFICIENCY	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA 31	0.0025640999999999997	0.12820499999999999
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0025640999999999997	0.12820499999999999
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0025640999999999997	0.12820499999999999
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0025640999999999997	0.12820499999999999
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0025640999999999997	0.12820499999999999
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0025640999999999997	0.12820499999999999
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0025640999999999997	0.12820499999999999
NYSTAGMUS, HEREDITARY VERTICAL	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0025640999999999997	0.12820499999999999
MACHADO-JOSEPH DISEASE; MJD	0.0025640999999999997	0.12820499999999999
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0025640999999999997	0.12820499999999999
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.0025640999999999997	0.12820499999999999
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0025640999999999997	0.12820499999999999
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0025640999999999997	0.12820499999999999
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0025640999999999997	0.12820499999999999
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0025640999999999997	0.12820499999999999
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0025640999999999997	0.12820499999999999
245800 LAURENCE-MOON SYNDROME	0.0025640999999999997	0.12820499999999999
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0025640999999999997	0.12820499999999999
TRYPTOPHANURIA WITH DWARFISM	0.0025640999999999997	0.12820499999999999
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0025640999999999997	0.12820499999999999
ACERULOPLASMINEMIA	0.0025640999999999997	0.12820499999999999
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0025640999999999997	0.12820499999999999
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0025640999999999997	0.12820499999999999
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0025640999999999997	0.12820499999999999
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0025640999999999997	0.12820499999999999
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0025640999999999997	0.12820499999999999
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.0025640999999999997	0.12820499999999999
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0025640999999999997	0.12820499999999999
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0025640999999999997	0.12820499999999999
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0025640999999999997	0.12820499999999999
WERNICKE-KORSAKOFF SYNDROME	0.0025640999999999997	0.12820499999999999
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0025640999999999997	0.12820499999999999
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.0025640999999999997	0.12820499999999999
DE SANCTIS-CACCHIONE SYNDROME	0.0025640999999999997	0.12820499999999999
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0025640999999999997	0.12820499999999999
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.0025640999999999997	0.12820499999999999
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0025640999999999997	0.12820499999999999
DEMENTIA, FAMILIAL DANISH	0.0025640999999999997	0.12820499999999999
KURU, SUSCEPTIBILITY TO	0.0025640999999999997	0.12820499999999999
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0025640999999999997	0.12820499999999999
OPTIC ATROPHY 1; OPA1	0.0025640999999999997	0.12820499999999999
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0025640999999999997	0.12820499999999999
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0025640999999999997	0.12820499999999999
JOUBERT SYNDROME 5	0.0025640999999999997	0.12820499999999999
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0025640999999999997	0.12820499999999999
SANDHOFF DISEASE	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0025640999999999997	0.12820499999999999
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0025640999999999997	0.12820499999999999
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0025640999999999997	0.12820499999999999
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0025640999999999997	0.12820499999999999
EPISODIC ATAXIA, TYPE 8	0.0025640999999999997	0.12820499999999999
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0025640999999999997	0.12820499999999999
GILLESPIE SYNDROME; GLSP	0.0025640999999999997	0.12820499999999999
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0025640999999999997	0.12820499999999999
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.0025640999999999997	0.12820499999999999
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0025640999999999997	0.12820499999999999
ABETALIPOPROTEINEMIA	0.0025640999999999997	0.12820499999999999
CEREBELLAR HYPOPLASIA	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0025640999999999997	0.12820499999999999
#615558 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1;;HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;;ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;;HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	0.0025640999999999997	0.12820499999999999
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0025640999999999997	0.12820499999999999
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0025640999999999997	0.12820499999999999
JOUBERT SYNDROME 4	0.0025640999999999997	0.12820499999999999
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0025640999999999997	0.12820499999999999
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0025640999999999997	0.12820499999999999
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.08798165
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.08798165
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.08798165
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.08798165
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.08798165
PRADER-WILLI SYNDROME; PWS	0.001759633	0.08798165
MACDERMOT-WINTER SYNDROME	0.001759633	0.08798165
Muenke syndrome	0.001759633	0.08798165
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.08798165
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.08798165
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.001759633	0.08798165
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.08798165
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.08798165
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.08798165
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.08798165
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.08798165
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.08798165
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.08798165
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.08798165
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.08798165
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.08798165
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.08798165
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.08798165
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.08798165
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.08798165
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.08798165
PHACE ASSOCIATION	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.08798165
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.08798165
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.08798165
DIGEORGE SYNDROME; DGS	0.001759633	0.08798165
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.08798165
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.08798165
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.08798165
HARTNUP DISORDER	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.08798165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.08798165
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.08798165
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.08798165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001759633	0.08798165
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.08798165
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.08798165
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.08798165
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.08798165
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.08798165
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001759633	0.08798165
LANDAU-KLEFFNER SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.08798165
PALLISTER-HALL SYNDROME	0.001759633	0.08798165
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.08798165
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.08798165
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001759633	0.08798165
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001759633	0.08798165
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.08798165
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001759633	0.08798165
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.08798165
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.08798165
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.08798165
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.08798165
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.08798165
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.08798165
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.08798165
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.08798165
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.08798165
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.08798165
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.08798165
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.08798165
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.08798165
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.08798165
WAISMAN SYNDROME; WSMN	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001759633	0.08798165
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001759633	0.08798165
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.08798165
SCHINDLER DISEASE, TYPE I	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.08798165
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.08798165
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.08798165
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.08798165
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.08798165
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.08798165
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.08798165
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.08798165
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.08798165
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001759633	0.08798165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.08798165
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.08798165
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.08798165
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.08798165
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.08798165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.08798165
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.08798165
KLEEFSTRA SYNDROME 2; KLEFS2	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.08798165
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.08798165
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.08798165
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.08798165
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.08798165
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.08798165
KBG SYNDROME	0.001759633	0.08798165
KETOADIPICACIDURIA	0.001759633	0.08798165
TIMOTHY SYNDROME; TS	0.001759633	0.08798165
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.08798165
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.08798165
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.04578755
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.04578755
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.04578755
HYPER-BETA-ALANINEMIA	0.000915751	0.04578755
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04578755
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.04578755
2q33.1 deletion syndrome	0.000915751	0.04578755
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04578755
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.04578755
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04578755
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04578755
TAY-SACHS DISEASE; TSD	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04578755
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.04578755
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.04578755
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.04578755
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.04578755
STURGE-WEBER SYNDROME	0.000915751	0.04578755
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.04578755
Angelman syndrome (Type 2)	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.04578755
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.04578755
CROUZON SYNDROME	0.000915751	0.04578755
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.04578755
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.04578755
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.04578755
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.04578755
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.04578755
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.04578755
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.04578755
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.04578755
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.04578755
PERRAULT SYNDROME 3	0.000915751	0.04578755
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.04578755
CRANIOSYNOSTOSIS 2	0.000915751	0.04578755
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.04578755
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.04578755
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04578755
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.04578755
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04578755
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04578755
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04578755
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04578755
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.04578755
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.04578755
PHENYLKETONURIA	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.04578755
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04578755
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04578755
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.04578755
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04578755
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04578755
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04578755
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04578755
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04578755
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04578755
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04578755
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.04578755
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.04578755
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.04578755
1p36 microdeletion syndrome	0.000915751	0.04578755
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.04578755
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04578755
INCONTINENTIA PIGMENTI; IP	0.000915751	0.04578755
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.04578755
SECKEL SYNDROME 1; SCKL1	0.000915751	0.04578755
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04578755
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.04578755
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.04578755
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.04578755
PARIETAL FORAMINA	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04578755
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.04578755
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.04578755
KLEEFSTRA SYNDROME	0.000915751	0.04578755
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.04578755
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.04578755
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04578755
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.04578755
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04578755
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.04578755
AUTISM	0.000915751	0.04578755
HYPERLYSINEMIA, TYPE I	0.000915751	0.04578755
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.04578755
DARIER-WHITE DISEASE; DAR	0.000915751	0.04578755
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.04578755
HYPERPROLINEMIA, TYPE II	0.000915751	0.04578755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04578755
GURRIERI SYNDROME	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.04578755
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.04578755
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.04578755
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04578755
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.04578755
FILIPPI SYNDROME; FLPIS	0.000915751	0.04578755
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.04578755
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.04578755
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.04578755
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04578755
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.04578755
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04578755
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04578755
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.04578755
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.04578755
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.04578755
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.04578755
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.04578755
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04578755
PAPILLORENAL SYNDROME	0.000915751	0.04578755
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.04578755
HHHH SYNDROME	0.000915751	0.04578755
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.04578755
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04578755
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04578755
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.04578755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.04578755
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.04578755
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04578755
KIFAFA SEIZURE DISORDER	0.000915751	0.04578755
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.04578755
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.04578755
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04578755
RAMON SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04578755
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04578755
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04578755
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.04578755
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.04578755
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04578755
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04578755
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04578755
Angelman syndrome (Type 1)	0.000915751	0.04578755
ALZHEIMER DISEASE 3; AD	0.000915751	0.04578755
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.04578755
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04578755
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.04578755
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.04578755
HUNTINGTON DISEASE; HD	0.000915751	0.04578755
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04578755
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04578755
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04578755
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.04578755
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04578755
EPILEPSY, READING	0.000915751	0.04578755
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.04578755
DYSOSTEOSCLEROSIS	0.000915751	0.04578755
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04578755
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.04578755
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04578755
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.04578755
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.04578755
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.04578755
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04578755
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.04578755
THREONINEMIA	0.000915751	0.04578755
Wolf-Hirschhorn Syndrome	0.000915751	0.04578755
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.0421941
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.0421941
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.0421941
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.0421941
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.0421941
CULLER-JONES SYNDROME; CJS	0.000843882	0.0421941
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.0421941
FRIAS SYNDROME	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.0421941
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.0421941
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.0421941
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.0421941
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.0421941
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.0421941
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.0421941
RAINE SYNDROME	0.000843882	0.0421941
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.0421941
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.0421941
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.0421941
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.0421941
Bardet-Biedl syndrome 2	0.000843882	0.0421941
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.0421941
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.0421941
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.0421941
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.0421941
CHAR SYNDROME	0.000843882	0.0421941
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.0421941
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.0421941
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.0421941
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.0421941
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.0421941
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.0421941
AUSTRALIA ANTIGEN	0.000843882	0.0421941
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.0421941
Temtamy preaxial brachydactyly syndrome	0.000843882	0.0421941
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.0421941
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.0421941
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.0421941
CDAGS SYNDROME	0.000843882	0.0421941
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.0421941
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.0421941
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.0421941
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.0421941
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.0421941
SENIOR-LOKEN SYNDROME 9	0.000843882	0.0421941
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.0421941
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.0421941
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.0421941
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.0421941
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.0421941
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.0421941
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.0421941
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.0421941
ALAZAMI-YUAN SYNDROME	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.0421941
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.0421941
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.0421941
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.0421941
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.0421941
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.0421941
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.0421941
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.0421941
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.0421941
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.0421941
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.0421941
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.0421941
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.0421941
NETHERTON SYNDROME; NETH	0.000843882	0.0421941
#300555 DENT DISEASE 2	0.000843882	0.0421941
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.0421941
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.0421941
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.0421941
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.0421941
JOUBERT SYNDROME 26	0.000843882	0.0421941
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.0421941
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.0421941
JOUBERT SYNDROME 24	0.000843882	0.0421941
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.0421941
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.0421941
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.0421941
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.0421941
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.0421941
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.0421941
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.0421941
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.0421941
OROTIC ACIDURIA	0.000843882	0.0421941
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.0421941
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.0421941
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.0421941
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.0421941
RAHMAN SYNDROME	0.000843882	0.0421941
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.0421941
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.0421941
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.0421941
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.0421941
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.0421941
AL-RAQAD SYNDROME; ARS	0.000843882	0.0421941
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.0421941
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.0421941
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.0421941
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.0421941
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.0421941
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.0421941
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.0421941
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.0421941
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.0421941
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.0421941
CHOPS SYNDROME; CHOPS	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.0421941
NOONAN SYNDROME 2; NS2	0.000843882	0.0421941
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.0421941
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.0421941
Jawad syndrome	0.000843882	0.0421941
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.0421941
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.0421941
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000843882	0.0421941
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.0421941
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.0421941
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.0421941
Cerebral creatine deficiency syndrome 3	0.000843882	0.0421941
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.0421941
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.0421941
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.0421941
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.0421941
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.0421941
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.0421941
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.0421941
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.0421941
Leukotriene C4 synthase deficiency	0.000843882	0.0421941
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.0421941
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.0421941
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.0421941
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.0421941
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.0421941
3MC SYNDROME 2	0.000843882	0.0421941
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.0421941
CURRARINO SYNDROME	0.000843882	0.0421941
SECKEL SYNDROME 8; SCKL8	0.000843882	0.0421941
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.0421941
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.0421941
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.0421941
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.0421941
Aarskog-Scott syndrome	0.000843882	0.0421941
NOONAN SYNDROME 9; NS9	0.000843882	0.0421941
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.0421941
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.0421941
SECKEL SYNDROME 9; SCKL9	0.000843882	0.0421941
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.0421941
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.0421941
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.0421941
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.0421941
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.0421941
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.0421941
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.0421941
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.0421941
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.0421941
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.0421941
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.0421941
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.0421941
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.0421941
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.0421941
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.0421941
STEEL SYNDROME; STLS	0.000843882	0.0421941
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.0421941
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.0421941
MEIER-GORLIN SYNDROME 7	0.000843882	0.0421941
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.0421941
LOWRY-MACLEAN SYNDROME	0.000843882	0.0421941
